Next Article in Journal
Human Pathogenic Bacteria Within the Nasal and Rectal Microbiome of Macropus giganteus
Previous Article in Journal
Underreporting of Adverse Events Following COVID-19 Vaccination Among Healthcare Professionals in Poland: Potential Implications for Vaccine Hesitancy
Previous Article in Special Issue
Praziquantel Pretreatment Reduces Schistosoma japonicum Infection in Mice by Targeting Immature Worm Stages
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Strongyloides stercoralis Infection in Humans in West Africa, 1975–2024: Systematic Review and Meta-Analysis

by
Rufin K. Assaré
1,2,3,4,*,
Mamadou Ouattara
1,2,
Sören L. Becker
3,4,5,
Fidèle K. Bassa
1,2,
Nana R. Diakité
1,2,
Jürg Utzinger
3,4 and
Eliézer K. N’Goran
1,2
1
Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, Abidjan 22 BP 582, Côte d’Ivoire
2
Environnement et Santé, Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan 01 BP 1303, Côte d’Ivoire
3
Epidemioloy and Public Health, Swiss Tropical and Public Health Institute, Kreuzstrasse 2, CH-4123 Allschwil, Switzerland
4
Faculty of Medicine, University of Basel, CH-4003 Basel, Switzerland
5
Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421 Homburg, Germany
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2025, 10(11), 321; https://doi.org/10.3390/tropicalmed10110321
Submission received: 2 September 2025 / Revised: 3 November 2025 / Accepted: 4 November 2025 / Published: 17 November 2025
(This article belongs to the Special Issue Research Advances and New Perspectives on Helminthic Diseases)

Abstract

Strongyloidiasis is an underappreciated helminth infection that belongs to a group of neglected tropical diseases. The aim of this systematic review and meta-analysis was to determine the pooled prevalence of Strongyloides stercoralis infection in humans in 16 West African countries. We searched African Journals Online, Embase, Horizon, Google Scholar, ProQuest, PubMed, Scopus, and Web of Science to identify articles assessing S. stercoralis prevalence data. The search was restricted to articles published between 1 January 1975 and 31 December 2024 without language restriction. We followed the PRISMA guidelines. A total of 21,250 articles were identified, 336 of which met the inclusion criteria. The most frequently used diagnostic tools were Kato-Katz (35.1%) and formol-ether coprological methods (23.4%). Strongyloidiasis was reported in 15 of the 16 West African countries; Mali was the only country where it was absent. The S. stercoralis regional prevalence was 4.4%, ranging from 0.2% in Burkina Faso to 18.9% in The Gambia. S. stercoralis infection prevalence decreased from 14.0% (1975–1984) to 4.1% (2015–2024). S. stercoralis prevalence showed strong heterogeneity with the highest prevalence mainly observed in countries in the Gulf of Guinea. Most of the employed diagnostic techniques were inappropriate; the reported S. stercoralis prevalence is, thus, likely an underestimation of the true situation. Our observations call for more sensitive S. stercoralis diagnostic tools and strategies for strongyloidiasis control that are tailored to the different social-ecological settings of West Africa.

1. Introduction

Strongyloidiasis is a neglected parasitic worm infection, which is predominantly caused by the nematode species Strongyloides stercoralis [1]. A recent review using spatio-temporal statistical modelling estimated that more than 600 million people might be infected with S. stercoralis worldwide [2]. Strongyloidiasis shows the highest prevalence in tropical and subtropical countries, particularly in areas with poor sanitation and hygiene conditions. Most often, S. stercoralis infection causes no overt symptomatology. However, chronic infection might cause diarrhoea, abdominal pain, skin rashes, Loeffler’s syndrome, dry cough, recurrent sore throat, loss of appetite, blood in stool, anaemia, heartburn, and bloating. In immunosuppressed people, strongyloidiasis can lead to hyperinfection syndromes and dissemination, which can be fatal. Infection with human T-lymphotropic virus 1 (HTLV-1), hypogammaglobulinaemia, malnutrition, corticosteroid consumption, diabetes mellitus, alcoholism, and chronic renal failure increase the risk of severe S. stercoralis infection [3,4,5].
Humans are primarily infected by S. stercoralis through the cutaneous route. Filariform larvae penetrate the skin of the host when walking barefoot. The larvae migrate to the lung, before finally reaching the intestine where the parthenogenic parasitic female worm produces eggs. The eggs rapidly hatch into rhabditiform larvae inside the host’s gut. Some rhabditiform larvae are excreted in soil and give rise to infectious filariform larvae, which are able to penetrate skin and restart the life cycle of the worm. The remaining rhabditiform larvae develop into filariform larvae in the host’s gut and penetrate the bowel wall, thereby establishing the autoinfective lifecycle. The helminth’s almost unique characteristic of parthenogenesis and autoinfection provides the basis for lifelong persistent infection, which can lead to hyperinfection.
Although ivermectin is recommended as an efficacious drug, control programmes for strongyloidiasis are lacking in endemic countries, particularly in sub-Saharan Africa. An important reason is that the prevalence of S. stercoralis infection is unknown or underestimated. Strongyloidiasis diagnosis is based on the identification of larvae in stool samples. However, most of the widely used diagnostic tools have low sensitivity because no eggs, only larvae, are shed in the faeces. More sensitive diagnostic approaches such as Koga agar plate (KAP) culture, Baermann, and polymerase chain reaction (PCR), are rarely used in field surveys in resource-constrained settings [6,7,8]. The Kato-Katz thick smear technique (KK) and direct faecal smear analysis have been mainly used in epidemiological surveys, although these techniques are better suited to detect helminth eggs than larvae; hence, they result in low S. stercoralis prevalence estimates. Over the past decade, several studies were conducted to assess the S. stercoralis prevalence. The prevalence of infection in the general population was estimated, and key risk factors were determined [2,3,9]. A recent review aimed to deepen the understanding of the epidemiology of strongyloidiasis in Africa based on different diagnostic techniques, study settings, and populations studied [10]. Considering cross-sectional surveys, the review reported data of S. stercoralis for five West African countries. In two of the included countries (i.e., Burkina Faso and Senegal), only one survey met the inclusion criteria. However, historical data on strongyloidiasis are available that date back to the 1970s for many West African countries.
The purpose of the current systematic review and meta-analysis was to determine the prevalence of S. stercoralis infection in West Africa stratified by country, decade, diagnostic method, sample size, study setting, and population. The results are important and might guide strongyloidiasis-control efforts in West Africa and elsewhere.

2. Materials and Methods

2.1. Search Strategy

The systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Table S1). The review protocol is available on the International Prospective Register of Systematic Reviews (PROSPERO) under registration number CRD42022332324.
We searched for relevant publications pertaining to S. stercoralis infection in West African countries, using the following databases: African Journals Online, Embase, Horizon, Google Scholar, ProQuest, PubMed, Scopus, and Web of Science. The search was restricted to studies on humans published between 1 January 1975 and 31 December 2024. There was no language restriction. The keywords “strongyloidiasis” and “parasitose” were used to search African Journals Online and Horizon, respectively. In Google Scholar, the search terms were “anguillulose” and “Strongyloides”, combined with the countries of West Africa (i.e., Benin, Burkina Faso, Cape Verde, Côte d’Ivoire, The Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, and Togo). For the remaining five online databases (i.e., Embase, ProQuest, PubMed, Scopus, and Web of Science), the search terms included the following Medical Subject Headings (MeSH): “strongyloidiasis”, “anguilllulose”, “anguillulosis”, “S. stercoralis”, “soil-transmitted helminth”, “anguillul*”, “strongyl*”, and “helminth*”. These search terms were used in combination with the Boolean operators “OR”, “AND”, and the name of the West African countries.

2.2. Selection Criteria

Studies were selected for the current review if: (i) they were observational or clinical studies; (ii) they were carried out in West African countries; (iii) had human stool or blood samples examined; and (iv) studies reported prevalence of S. stercoralis infection or provided data on sample size and number of infected individuals. We excluded studies that focused on animal infections, reviews, commentaries, editorials (expert opinions), and symposia. Studies conducted on people coming from West Africa but living outside this region were also excluded. Additionally, articles were excluded if the full text was not available.

2.3. Data Extraction

The first author conducted the literature search. A second researcher double-checked the recorded articles based on the study inclusion and exclusion criteria. In case of discrepancies, a third researcher was consulted until agreement was reached.
The following information was retrieved: first author, year of publication, location, country, study design, study setting, study population, time of field work, diagnostic method, number of male participants, number of S. stercoralis-positive males, number of female participants, number of S. stercoralis-positive females, individual sample size, and number of S. stercoralis-positive individuals, S. stercoralis prevalence, and 95% confidence intervals (CIs) were estimated.

2.4. Quality Assessment

The quality of the included studies was assessed, using the checklist of Joanna Briggs Institute (JBI) for quality assessment of prevalence studies tools [11]. This checklist is a questionnaire-based method with nine specific items; namely (i) sample frame appropriate to address the target population; (ii) study participants sampled in an appropriate way; (iii) adequate sample size; (iv) study subjects and the setting described in detail; (v) data analysis conducted with sufficient coverage of the identified sample; (vi) valid methods used for the identification of the condition; (vii) the conditions measured in a standard and reliable way for all participants; (viii) appropriate statistical analysis; and (ix) adequate response rate. The responses were scored as 1 indicating “yes” and 0 meaning “not reported”. For each included article, the total score of “yes” responses were calculated and classified into three categories, as follow: ‘high risk of bias’ (low quality), ‘moderate risk of bias’ (moderate quality), and ‘low risk of bias’ (high quality) if the total scores of “yes” was <5, 5–7, and 8–9, respectively. Low quality articles were included in the final analysis.

2.5. Statistical Analysis

Data entry was performed using an Excel 2016 spreadsheet, while the meta-analysis was performed using STATA version BE 18.0 (Stata Corporation; College Station, TX, USA). The prevalence of S. stercoralis infection and its 95% CI were calculated using the exact binomial interval (http://statpages.info/confint.html. Accessed from 20 January 2025 to 15 February 2025). Cochran’s Q test and I2 statistic test were utilised to assess for heterogeneity among the included studies. The heterogeneity was considered as low, moderate, or high when the I2 value was above 25%, 50%, and 75%, respectively. Cochran’s Q test with p-value < 0.10 confirmed that there was statistically significant heterogeneity between the studies. Forest plots were generated to estimate the pooled effect size and to display a visual summary of the data. The correlation between strongyloidiasis and risk factors was measured based on the odds ratio and corresponding 95% CI. Funnel plots were generated, and Egger’s regression test was performed to assess publication bias between studies. p-value < 0.05 corresponds to the presence of publication bias across studies.
Subgroup analysis was conducted by decade of publication, country, diagnostic method, study population, categories of sample size, and study setting. A map of strongyloidiasis prevalence in West African countries was generated using QGIS version 3.4 Madeira (QGIS Development Team, Open Source Geospatial Foundation).

3. Results

3.1. Study Selection

A total of 21,250 articles were identified through our search of the eight electronic databases (Figure 1). After removing 10,918 duplicates, another 8584 articles were excluded based on careful study of the abstract. Full text analysis of the remaining articles resulted in the exclusion of another 1609 articles due to different reasons. Overall, 138 articles fulfilled our inclusion criteria and 11 (8.0%) of these articles were specifically designed to assess S. stercoralis infection. Considering, separately, articles that were conducted in more than one setting, 336 individual studies were included in this systematic review and meta-analysis.

3.2. Characteristics of the Included Studies

The detailed characteristics of the included studies are summarised in Table 1. We found data for 15 of the 16 West African countries. In Mali, no data for S. stercoralis were reported. The highest number of individual studies was reported from Nigeria (n = 119), followed by Benin (n = 67), and Côte d’Ivoire (n = 46). Only one individual study was carried out in each of the two countries Cape Verde and Niger. The highest number of individual studies was published in 2021 (n = 69), followed by 2014 (n = 36), and 2016 (n = 32) (Figure 2). A total of 143,112 individuals were enrolled in the selected studies (Table 1). More than half (193 out of 336) of the included individual studies focused on school-aged children, whereas 13 individual studies assessed strongyloidiasis specifically in females. Approximately three-fifths (196/336) of the individual studies were conducted in schools, whereas the remaining individual studies were carried out in the community (n = 98) or in hospital settings (n = 42).
Most of the individual studies (n = 166) had sample sizes lower than or equal to 100 participants (Table 2). The highest sample size was 20,250 participants (a study conducted in the North and Upper Eastern Region of Ghana), while the lowest number of participants were enrolled in a study in Ujagba, Nigeria (9 participants) and Diowle, Mauritania (8 participants; Table S2). The prevalence of S. stercoralis infection of the included individual studies ranged from 0% to 54.0%. The infection prevalence of S. stercoralis decreased from 14.0% (95% CI: 6.9–21.2%) in the period 1975–1984 to 3.8% (95% CI: 3.2–4.3%) in 2015–2024 (Figure 3). Considering 2010 as the time limit and 20% as the S. stercoralis prevalence limit; the proportion of individual studies where the infection prevalence exceeded 20% after 2010 (4.6%) was more than two times lower than the corresponding value (10.0%) from 1975 to 2010 (Figure 3). Most of the highest sample sizes (>1000 participants) were reported after 2000 (80.8%, 21/26). The individual studies were predominantly carried out in schools.
The KK technique (n = 118, 35.1%) was the predominant diagnostic approach, followed by the formol-ether (FE) method (n = 79, 23.5%) (Figure 4).

3.3. Quality of Studies

Table S3 summarises the results of the included articles’ quality assessment. The quality score of the articles ranged from 4 to 9 on a scale from 0 to 9. Approximately, four-fifths (n = 110) of the included articles were of moderate quality, while 19.6% (27 articles) and 0.7% (n = 1) were of high and low quality, respectively. The average score was 6.6 and shows that the overall quality of the publications included in this analysis was moderate.

3.4. Publication Bias

Funnel plot symmetry indicated the presence of publication bias among the included individual studies (Figure S1A). Egger’s regression test result revealed a significant publication bias across the included individual studies that were meta-analysed (p < 0.001).

3.5. Meta-Regression Analysis

The overall pooled prevalence of S. stercoralis infection in West Africa was 4.4% (95% CI: 4.1–4.8%). There was considerable heterogeneity across the individual studies selected in this review (I2 = 96.8%, p < 0.001). Our meta-regression analysis revealed that the sample size of the study population (regression coefficient: 0.42, 95% CI: 0.34–0.53, p < 0.001) significantly contributed to the heterogeneity across the included individual studies (Figure S1B). In contrast, decade of publication (p = 0.141), study country (p = 0.812), diagnostic method used (p = 0.540), study population (p = 0.478), and study setting (p = 0.433) were no significant sources of heterogeneity among the selected individual studies (Table 3).

3.6. Strongyloidiasis in West Africa

Figure 5 displays the pooled prevalence of strongyloidiasis across West Africa. The highest pooled prevalence of S. stercoralis infection was reported in The Gambia (≥15%), followed by Liberia and Togo with an estimated prevalence ranging from 10.0% to 14.9%. S. stercoralis prevalence ranged from 5.0% to 9.9% in Cape Verde, Côte d’Ivoire, Guinea, Guinea-Bissau, Nigeria, and Sierra Leone. In the remaining six countries, the prevalence of S. stercoralis infection was below 5%.
Table 4 summarises the pooled S. stercoralis infection prevalence by country, while the visual presentation of these findings are shown in Figure 6A–E. The highest pooled prevalence of S. stercoralis infection was reported from The Gambia when using KK (18.9%, 95% CI: 11.1–26.8%, high heterogeneity: I2 = 88.4%, p < 0.001). The second highest prevalence was found in Liberia (14.9%, 95% CI: 9.8–19.9%, I2 = 62.3%, p = 0.103), and the third in Togo (10.7%, 95% CI: 6.9–92.3%, I2 = 92.3, p < 0.001). In Liberia, direct analysis (DA) was used as diagnostic tool, while in Togo, 7 out of 10 individual studies employed an enzyme-linked immunosorbent assay (ELISA) technique. Almost all the individual studies in The Gambia (18 out of 19 individual studies) and the individual studies in Liberia (2 studies) were conducted at schools.
The lowest pooled prevalence of S. stercoralis was 0.2% (95% CI: 0.1–0.2%) and 0.3% (95% CI: 0.0–0.6%) recorded in Burkina Faso and Niger, respectively. In Burkina Faso, the selected individual studies (n = 5) were carried out in hospitals, three of them targeting females. A combination of DA, Ritchie, and Willis methods were used in three individual studies, a combination of DA and FE was used in one study, and DA was used in one individual study in Burkina Faso. The study in Niger was community-based and used the FE method for diagnosis. In Nigeria, a relative higher number of participants 47,705 (33.3%) were enrolled in 119 individual studies and the pooled prevalence was 5.1% (95% CI: 4.4–5.9%) with considerable heterogeneity (I2 = 96.6%, p < 0.001). Approximately three-fifths of the individual studies (69/119 individual studies) were school-based and 61.0% (72/119 individual studies) used FE concentration method.

3.7. Subgroup Analysis

3.7.1. S. stercoralis Prevalence by Decade of Publication

Forest plots using random effects model indicated that the highest pooled S. stercoralis prevalence was 14.0% (95% CI: 6.9–21.2%) reported from 1975 to 1984 (Figure S2A,B). The lowest prevalence of infection was 3.8% (95% CI: 3.2–4.3%) recorded in the years 2015–2024 (Figure S2C–E).

3.7.2. Prevalence of S. stercoralis by Study Population (Age Group)

Among the included individual studies, 193 (57.4%), 13 (3.9%), and 10 (3.0%) were conducted specifically among school-aged children, women, and pre-school-aged children, respectively (Table 2). Twenty-eight (8.3%) of the included individual studies were pre-school-aged and school-based studies. Age categories of 81,559 participants were not mentioned. The highest S. stercoralis prevalence was 7.1% (95% CI: 6.1–8.1%, I2 = 90.4%, p < 0.001) and was reported in school-aged children, followed by 6.3% (95% CI: 3.7–8.9%, I2 = 83.0%, p < 0.001) reported in pre-school-aged children. In contrast, the lowest pooled S. stercoralis prevalence was of 1.6% (95% CI: 0.8–2.4%, I2 = 75.9%, p < 0.001) was obtained in individual studies which focused on female populations.

3.7.3. Prevalence of S. stercoralis by Setting

Overall, 196 (58.3%) individual studies were carried out in schools. The remaining individual studies were either performed in communities (n = 98, 29.2%) or in hospitals (n = 42, 12.5%) (Table 1). The pooled S. stercoralis prevalence was 6.6% (95% CI: 5.7–7.5%, I2 = 98.3%, p < 0.001) in community-based studies, 5.5% (95% CI: 4.7–6.3%, I2 = 91.5%, p < 0.001) in school-based studies, and 1.5% (95% CI: 1.2–1.8%, I2 = 91.0%, p < 0.001) in hospital-based studies (Table 2). There were no significant differences in the pooled prevalence of S. stercoralis between the individual studies conducted in schools and those conducted in communities. In contrast, S. stercoralis prevalence in school-based and community-based studies were significantly higher compared to individual studies conducted in hospitals.

3.7.4. Prevalence of S. stercoralis by Sample Size

There were 166 individual studies with a sample size of 100 participants or less (9111 individuals). In 144 individual studies the number of participants ranged between 101 and 1000 (45,977 individuals), 23 individual studies had a sample size of 1001 to 10,000 participants (42,661 individuals), and 3 individual studies included more than 10,000 participants each (45,363 individuals) (Table 2). The highest pooled S. stercoralis infection prevalence was found in individual studies with sample sizes lower than, or equal to, 100 participants (9.1%, 95% CI: 7.4–10.7%, I2 = 80.5%, p < 0.001) and the lowest prevalence of S. stercoralis was observed in individual studies with sample sizes ranging between 1001 and 10,000 participants (3.1%, 95% CI: 2.4–3.8%, I2 = 98.7, p < 0.001). The pooled S. stercoralis prevalence was significantly higher in study categories with sample sizes of 100 participants, or fewer, compared to individual studies with sample sizes higher than 100 participants.

3.7.5. Prevalence of S. stercoralis by Gender

Among the included individual studies, 11 stratified S. stercoralis data by gender. Forest plots revealed that S. stercoralis prevalence was 4.7% (95% CI: 0.8–8.6%, I2 = 98.3%, p < 0.001) in females and 4.6% (95% CI: 0.3–8.8%, I2 = 98.6%, p < 0.001) in male participants (Figure S3). There was no statistical significant difference in prevalence of S. stercoralis by gender.

3.7.6. Approaches for Strongyloidiasis Diagnosis

Table S4 summarises the characteristics of the diagnostic methods used in the included individual studies. Most individual studies employed KK (118, 35.1%), FE (79, 23.5%), and DA (23, 6.8%) for strongyloidiasis diagnosis. DA plus FE (22, 6.7%) was the combination of diagnostic tools frequently reported. The highest prevalence of S. stercoralis was 33.9% (95% CI: 24.8–43.1%) and obtained using a combination of FLOTAC, FE, KK, and KAP, followed by 33.3% (95% CI: 27.3–39.4%) recorded using a combination of KK and mertiolate iodine formaldehyde concentration (MIFC), and 33.0% (95% CI: 27.5–38.5%) using a combination of DA and merthiolate-formaldehyde concentration (MFC). When a combination of Baermann and KAP was used, the S. stercoralis prevalence was 18.8%. S. stercoralis prevalence was 12.6% using a combination of five diagnostic methods, namely Baermann, FLOTAC, FE, KK, and KAP. Among the individual studies that used only one diagnostic tool, the highest pooled strongyloidiasis prevalences were 17.1% (95% CI: 7.4–26.8%) observed by ELISA and 11.6% (95% CI: 11.2–12.1%) reported using coproculture (charcoal culture). The lowest pooled strongyloidiasis prevalence was 1.6% (95% CI: 0.5–2.7%), 2.5 (95% CI: 0.5–2.7%), 3.2% (95% CI: 1.1–5.3%), and 3.5% (95% CI: 2.8–4.1%) recorded using Ritchie, MBA, Roman, and KK technique, respectively.

3.8. Risk Factors for S. stercoralis Infection

Table 5 summarises the characteristics of risk factors for S. stercoralis infection in West Africa. Twelve individual studies were included to determine the risk factors for S. stercoralis infection. There were five types of predictors: diseases (HIV and malaria), symptoms (anaemia, stomach ache, and nausea), water, sanitation, and hygiene indicators (WASH, e.g., use of community tap water, availability of water or tissue for use after defaecation, availability of water and/soap after defaecation), demographic parameters (gender and age categories), and intervention. HIV (n = 5) was the main S. stercoralis infection predictor reported, followed by malaria (two studies) (Figure 7). The odds of S. stercoralis infection was higher among HIV patients compared to HIV-negative people (OR = 1.2, 95% CI: 0.9–1.5). However, there was no significant difference in pooled prevalence of S. stercoralis between HIV patients compared to HIV-negative people. Malaria patients were at higher odds of being infected with S. stercoralis larvae than malaria-negative individuals (OR = 1.4, 95% CI: 0.1–2.7), but there was no significant difference in pooled prevalence of S. stercoralis between malaria patients and their counterparts without the disease.

4. Discussion

Strongyloidiasis is an underappreciated parasitic worm infection, which can be partially explained by the challenge of accurate diagnosis, particularly in resource-constrained settings [1,150]. As a consequence, strongyloidiasis is usually not included in control programmes, although the combination of albendazole and ivermectin used for lymphatic filariasis and soil-transmitted helminthiasis also impacts strongyloidiasis [151,152]. The endemicity of strongyloidiasis is unknown across large parts of West Africa. The aim of the systematic review and meta-analysis presented here was to fill an important gap by providing the pooled S. stercoralis prevalence. We found an overall pooled S. stercoralis prevalence of slightly lower than 5% with considerable heterogeneity (I2 = 96.8%). This result is in line with studies conducted among children in urban settings in Côte d’Ivoire [33,36,44], Nigeria [96], and Senegal [145]. In contrast, our estimate was considerably lower than the overall prevalence of S. stercoralis reported in rural areas among schoolchildren in south-central and south-eastern parts of Côte d’Ivoire (27.0%) [39]. Similarly, a considerably higher prevalence of S. stercoralis infection (64.5%) was observed in a study carried out in rural populations of two regions in central and southern Togo [15]. One plausible explanation of the relative lower prevalence of S. stercoralis in West African countries might be the main objective and diagnostic methods of the studies. Among the included studies in this review, less than 10% were specifically designed to study the epidemiology of S. stercoralis. Hence, most of the diagnostic methods utilised in these studies only had a low sensitivity for S. stercoralis diagnosis, such as KK and FE methods, resulting in very low S. stercoralis detection rate. The observed strongyloidiasis cases were mainly accidental. The reported high S. stercoralis prevalence in some studies could be due to the characteristics of the study areas and the diagnostic methods used. Indeed, the studies in the two regions of Côte d’Ivoire and Togo were carried out in rural areas which provided suitable conditions for S. stercoralis transmission. In addition, sensitive S. stercoralis diagnostic tools, such as Baermann, KAP, and ELISA were used leading to the relatively high Strongyloides prevalence [38,153].
Our findings revealed that in West Africa the prevalence of S. stercoralis varied considerably, from less than 1% in Burkina Faso to 18.9% in The Gambia. This observation might be due to characteristics of the study population, environmental features, and socioeconomic status, which vary between, and within, countries. In Nigeria, where the highest number of the included studies was reported, the prevalence of S. stercoralis was 5.1% and was similar to the result (4.9%) of a recent systematic review and meta-analysis on S. stercoralis prevalence, diagnostic methods, and settings in Africa [10]. In Côte d’Ivoire, where the third highest number of studies (n = 46) included in our meta-analysis, the pooled prevalence of S. stercoralis was approximately the same (5.2%), which is significantly lower than 24.5% presented in a recent review [10]. The difference in the prevalence of S. stercoralis in Côte d’Ivoire may be due to the number of eligible studies and diagnostic methods used. Indeed, in the aforementioned review, two studies using the PCR technique were included, while in the current systematic review, microscopy-based techniques were predominantly utilised for diagnosis. It is widely acknowledged that DNA-based techniques are more sensitive than parasitological approaches [154,155]. Hence, the studies using DNA-based techniques produced higher prevalence of S. stercoralis infection than the parasitological studies.
Our findings revealed that considering different diagnostic tools, charcoal culture was more sensitive to the detection of S. stercoralis than the Baermann method. However, previous studies showed that charcoal culture was less sensitive than the Baermann method [156]. The relatively higher S. stercoralis prevalence using charcoal culture found in the current review might be due to the very high sample size (20,250 individuals) in the study carried out in the northern part of Ghana [134].
The results of the current review showed that the prevalence of S. stercoralis was lower when using the commonly employed Baermann method (5.1%). This observation corroborates observations from the south-central part of Côte d’Ivoire (8.2%) and the south-western part of Angola [31,157]. The findings indicated that the association of Baermann with KAP increased the estimated prevalence of S. stercoralis three-fold. These findings suggest that although the combination of diagnostic methods can lead to an increase in the prevalence of S. stercoralis [10,158,159], several other components of the association, such as sample size, characteristics of the study population, and environmental parameters might significantly influence the occurrence of S. stercoralis infection.
Considering one diagnostic technique, the highest prevalence of S. stercoralis infection was found using the ELISA technique. This observation confirms that the ELISA technique is a promising tool for S. stercoralis diagnosis. However, the limitation of the ELISA technique is the cross-reactions with other helminths which might overestimate the prevalence of S. stercoralis infection [160].
Our systematic review, including 336 individual studies, indicated that the magnitude of the pooled S. stercoralis prevalence in West Africa decreased significantly from 10.9% in 1975–1984 to 4.3% in 2015–2024. The decreasing trend could be attributed to social and economic development, and the establishment and long-term monitoring of onchocerciasis control programmes based on ivermectin treatment over large parts of West Africa, starting in the 1990s [161]. Another reason for the reduction in the pooled prevalence of S. stercoralis infection could be attributed to the implementation of the London Declaration by governments and non-governmental organisations who support the control of helminthiasis and other neglected tropical diseases through large-scale mass drug administrations and Vitamin A supplementation campaigns using albendazole tablets [162,163].
Our findings revealed that the highest S. stercoralis prevalences were found among school-aged children, followed by pre-school-aged children. Hence, the strongyloidiasis programmes should target pre-school- and school-aged children for the control of the disease. In addition, adult population at high risk, such as pregnant women and immunosuppressed individuals, should also be targeted during treatment campaigns. In addition, adult populations are barely covered by studies conducted thus far. Hence, it would be biologically plausible that the prevalence rises with age.
The results of the current review revealed that the odds of S. stercoralis infection was not significantly different among HIV patients and malaria-positive people compared to healthy individuals. These findings differ with results of studies among HIV-positive people and pregnant women in Ghana and Nigeria [88,89]. The finding in the current review might be due to the characteristics and limited number of the studies. Prior observations suggest that HIV and malaria patients are particularly vulnerable to S. stercoralis infection [69,85]. These infectious diseases might increase the risk of strongyloidiasis. Thus, it is important to examine all patients with HIV and malaria for concurrent S. stercoralis infection.

Strengths and Limitations

A limitation of the current review is the use of only online databases, coupled with a large variety of diagnostic tools in different social-ecological settings. Another limitation is the predominance of studies that were not primarily focused on Strongyloides, and hence, lacked data on specific high-risk populations such as adults, pregnant women, people with HIV, or malaria patients. However, the use of eight readily available databases and the inclusion of studies published in the past 50 years, regardless of language, increased considerably the sensitivity of the search strategy and resulted in strong evidence of the provided data. Of note, our data will become available via the Global Neglected Tropical Diseases (GNTD) database for decision-makers and other stakeholders dedicated to the epidemiology and control of strongyloidiasis and other neglected tropical diseases.

5. Conclusions

The current review revealed that S. stercoralis infection is reported in all but one of the 16 West African countries. S. stercoralis infection prevalence did not differ between pre-school-aged and school-aged children. These findings confirm the importance of including strongyloidiasis along soil-transmitted helminthiasis control programmes and to consider pre-school-aged children in targeted populations in the control strategies. Parasitological tools commonly used as diagnostic techniques have low sensitivity for S. stercoralis diagnosis. Hence, the reported S. stercoralis prevalence is likely an underestimation of the true situation. This observation calls for more sensitive diagnostic tools for an accurate estimation of the true strongyloidiasis distribution and public health problem. We recommend governments of West Africa to promote WASH, coupled with setting-specific information, education, and communication strategies, in order to lower the burden of strongyloidiasis. The highest prevalences of S. stercoralis infection was observed in the Gulf of Guinea. Future research should assess the prevalence and intensity of S. stercoralis infection using sensitive diagnostic approaches and determine associated risk factors. Particular emphasis should be placed on the impact of the geographic parameters on the disease burden in the context of climate change.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/tropicalmed10110321/s1, Figure S1A: Funnel plot for the prevalence of S. stercoralis infection; Egger’s test (p < 0.001); Figure S1B: Meta-regression plot of categories of sample size (p < 0.001); Figure S2. Prevalence of S. stercoralis infection in West Africa (A: from 1975 to 1984, B: from 1985 to 1994); Figure S2C. Prevalence of S. stercoralis infection in West Africa between 1995 and 2004; Figure S2D. Prevalence of S. stercoralis infection in West Africa between 2005 and 2014; Figure S2E. Prevalence of S. stercoralis infection in West Africa between 2015 and 2024; Figure S3. Prevalence of S. stercoralis infection in West Africa by sex (A: Prevalence of S. stercoralis in males, B: Prevalence of S. stercoralis in females); Table S1: The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses; Table S2: Characteristics of the included studies; Table S3: Quality assessment of the included studies; Table S4. Pooled prevalence of S. stercoralis infection in West Africa by diagnostic techniques.

Author Contributions

Conceptualization, R.K.A. and E.K.N.; Methodology, R.K.A. and E.K.N.; Data Curation, R.K.A. and E.K.N., Writing—Original Draft Preparation, R.K.A., J.U. and S.L.B., Writing—Review and Editing: R.K.A., F.K.B., N.R.D., E.K.N., J.U. M.O. and S.L.B. Analysis and interpretation of data, R.K.A. and E.K.N.; Approval of final submission, all authors. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data used in this systematic review and meta-analysis will be freely available on Global Neglected Tropical Diseases website (www.gntd.org).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Gordon, C.A.; Utzinger, J.; Muhi, S.; Becker, S.L.; Keiser, J.; Khieu, V.; Gray, D.J. Strongyloidiasis. Nat. Rev. Dis. Primers 2024, 10, 6. [Google Scholar] [CrossRef]
  2. Buonfrate, D.; Bisanzio, D.; Giorli, G.; Odermatt, P.; Fürst, T.; Greenaway, C.; French, M.; Reithinger, R.; Gobbi, F.; Montresor, A.; et al. The global prevalence of Strongyloides stercoralis infection. Pathogens 2020, 9, 468. [Google Scholar] [CrossRef] [PubMed]
  3. Schar, F.; Trostdorf, U.; Giardina, F.; Khieu, V.; Muth, S.; Marti, H.; Vounatsou, P.; Odermatt, P. Strongyloides stercoralis: Global distribution and risk factors. PLoS Negl. Trop. Dis. 2013, 7, e2288. [Google Scholar] [CrossRef] [PubMed]
  4. Scowden, E.B.; Schaffner, W.; Stone, W.J. Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine 1978, 57, 527–544. [Google Scholar] [CrossRef] [PubMed]
  5. Berk, S.L.; Verghese, A.; Alvarez, S.; Hall, K.; Smith, B. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch. Intern. Med. 1987, 147, 1257–1261. [Google Scholar] [CrossRef]
  6. Nielsen, P.B.; Mojon, M. Improved diagnosis of Strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Bakteriol. Mikrobiol. Hyg. A 1987, 263, 616–618. [Google Scholar] [CrossRef]
  7. Siddiqui, A.A.; Berk, S.L. Diagnosis of Strongyloides stercoralis infection. Clin. Infect. Dis. 2001, 33, 1040–1047. [Google Scholar] [CrossRef]
  8. Buonfrate, D.; Formenti, F.; Perandin, F.; Bisoffi, Z. Novel approaches to the diagnosis of Strongyloides stercoralis infection. Clin. Microbiol. Infect. 2015, 21, 543–552. [Google Scholar] [CrossRef]
  9. Eslahi, A.V.; Badri, M.; Nahavandi, K.H.; Houshmand, E.; Dalvand, S.; Riahi, S.M.; Johkool, M.G.; Asadi, N.; Ahangari, S.A.H.; Taghipour, A.; et al. Prevalence of strongyloidiasis in the general population of the world: A systematic review and meta-analysis. Pathog. Glob. Health 2021, 115, 7–20. [Google Scholar] [CrossRef]
  10. Hailu, T.; Nibret, E.; Amor, A.; Munshea, A. Strongyloidiasis in Africa: Systematic review and meta-analysis on prevalence, diagnostic Methods, and Study Settings. BioMed Res. Int. 2020, 2020, 2868564. [Google Scholar]
  11. JBI. The Joanna Briggs Institute Critical Appraisal Tools for Use in JBI Systematic Reviews: Checklist for Prevalence Studies. 2017. Available online: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Prevalence_Studies2017_0.pdf (accessed on 21 November 2023).
  12. Kositz, C.; Drammeh, M.; Vasileva, H.; Houghton, J.; Ashall, J.; D’Alessandro, U.; Marks, M.; Bradley, J. Effects of ivermectin mass drug administration for malaria vector control on ectoparasites and soil-transmitted helminths: A cluster randomized trial. Int. J. Infect. Dis. 2022, 125, 258–264. [Google Scholar] [CrossRef]
  13. Sanyang, A.M.; Joof, E.; Sey, A.P.; Sambou, S.; Mohamed, Z.; Sanneh, B. Prevalence and risk factors of strongyloidiasis among schoolchildren in Sabach Sanjal and Upper Badibou districts in the North Bank East Region of The Gambia. Parasite Epidemiol. Control 2021, 15, e00228. [Google Scholar] [CrossRef]
  14. Sodeman, W.A., Jr. A longitudinal study of schistosome vector snail populations in Liberia. Am. J. Trop. Med. Hyg. 1979, 28, 531–538. [Google Scholar] [CrossRef] [PubMed]
  15. Korbmacher, F.; Komlan, K.; Gantin, R.G.; Poutouli, W.P.; Padjoudoum, K.; Karabou, P.; Soboslay, P.T.; Kohler, C. Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo. Parasite Epidemiol. Control 2018, 3, 77–87. [Google Scholar] [CrossRef] [PubMed]
  16. Gbadoe, A.D.; Koffi, K.S. Parasitoses intestinales chez les enfants de moins de cinq ans au Togo et recommandations de la PCIME. Arch. Pediatr. 2005, 12, 1404. [Google Scholar] [CrossRef] [PubMed]
  17. Aplogan, A.; Schneider, D.; Dyck, J.L.; Berger, J. Parasitoses digestives chez le jeune enfant en milieu extra-hospitalier tropical. Ann. Pédiatr. 1990, 37, 677–681. [Google Scholar]
  18. Lapierre, J.; Tourte-Schaeffer, C.; Dupouy-Camet, J.; Heyer, F.; Faurant, C. Etude épidémiologique du foyer de bilharziose à Schistosoma mansoni de Kara (Nord Togo). Bull. Soc. Pathol. Exot. 1988, 81, 861–868. [Google Scholar]
  19. Farrant, O.; Marlais, T.; Houghton, J.; Goncalves, A.; Cassama, E.T.S.; Cabral, M.G.; Nakutum, J.; Manjuba, C.; Rodrigues, A.; Mabey, D.; et al. Prevalence, risk factors and health consequences of soil-transmitted helminth infection on the Bijagos Islands, Guinea Bissau: A community-wide cross-sectional study. PLoS Negl. Trop. Dis. 2020, 14, e0008938. [Google Scholar] [CrossRef]
  20. von Huth, S.; Kofoed, P.E.; Holmskov, U. Prevalence and potential risk factors for gastrointestinal parasitic infections in children in urban Bissau, Guinea-Bissau. Trans. R. Soc. Trop. Med. Hyg. 2019, 113, 545–554. [Google Scholar] [CrossRef]
  21. Steenhard, N.R.; Ornbjerg, N.; Molbak, K. Concurrent infections and socioeconomic determinants of geohelminth infection: A community study of schoolchildren in periurban Guinea-Bissau. Trans. R. Soc. Trop. Med. Hyg. 2009, 103, 839–845. [Google Scholar] [CrossRef]
  22. Lebbad, M.; Norrgren, H.; Naucler, A.; Dias, F.; Andersson, S.; Linder, E. Intestinal parasites in HIV-2 associated AIDS cases with chronic diarrhoea in Guinea-Bissau. Acta Trop. 2001, 80, 45–49. [Google Scholar] [CrossRef]
  23. Carstensen, H.; Hansen, H.L.; Kristiansen, H.O.; Gomme, G. The epidemiology of cryptosporidiosis and other intestinal parasitoses in children in southern Guinea-Bissau. Trans. R. Soc. Trop. Med. Hyg. 1987, 81, 860–864. [Google Scholar] [CrossRef] [PubMed]
  24. Bailey, M.S.; Thomas, R.; Green, A.D.; Bailey, J.W.; Beeching, N.J. Helminth infections in British troops following an operation in Sierra Leone. Trans. R. Soc. Trop. Med. Hyg. 2005, 100, 842–846. [Google Scholar] [CrossRef] [PubMed]
  25. Gbakima, A.A. Intestinal parasitic infections and swamp development in Sierra Leone. Afr. J. Health Sci. 1994, 1, 175–178. [Google Scholar] [PubMed]
  26. Whitworth, J.A.G.; Morgan, D.; Maude, G.H.; McNicholas, A.M.; Taylor, D.W. A field study of the effect of ivermectin on intestinal helminths in man. Trans. R. Soc. Trop. Med. Hyg. 1991, 85, 232–234. [Google Scholar] [CrossRef]
  27. Colito, D.A.; Dorta-Guerra, R.; Da Costa Lima, H.S.; Pina, C.; Gonsalvez, D.; Valladares, B.; Foronda, P. Intestinal parasites among children with diarrhoea from Santiago (Cape Verde). Arch. Dis. Child. 2021, 106, 828–830. [Google Scholar] [CrossRef]
  28. Beavogui, A.H.; Cherif, M.S.; Camara, B.S.; Delamou, A.; Kolie, D.; Cisse, A.; Camara, D.; Sow, A.; Camara, G.; Yattara, M.; et al. Prevalence of parasitic infections in children of Boke, Guinea. J. Parasitol. 2021, 107, 783–789. [Google Scholar] [CrossRef]
  29. Glickman, L.T.; Camara, A.O.; Glickman, N.W.; McCabe, G.P. Nematode intestinal parasites of children in rural Guinea, Africa: Prevalence and relationship to geophagia. Int. J. Epidemiol. 1999, 28, 169–174. [Google Scholar] [CrossRef]
  30. Gyorkos, T.W.; Camara, B.; Kokoskin, E.; Carabin, H.; Prouty, R. Enquête de prévalence parasitaire chez les enfants d’âge scolaire. Sante 1996, 6, 377–381. [Google Scholar]
  31. Becker, S.L.; Piraisoody, N.; Krammé, S.; Marti, H.; Silue, K.D.; Panning, M.; Nickel, B.; Kern, W.V.; Herrmann, M.; Hatz, C.F.; et al. Real-time PCR for detection of Strongyloides stercoralis in human stool samples from Côte d’Ivoire: Diagnostic accuracy, inter-laboratory comparison and patterns of hookworm co-infection. Acta Trop. 2015, 150, 210–217. [Google Scholar] [CrossRef]
  32. Becker, S.L.; Chatigre, J.K.; Gohou, J.-P.; Coulibaly, J.T.; Leuppi, R.; Polman, K.; Chappuis, F.; Mertens, P.; Herrmann, M.; N’Goran, E.K.; et al. Combined stool-based multiplex PCR and microscopy for enhanced pathogen detection in patients with persistent diarrhoea and asymptomatic controls from Côte d’Ivoire. Clin. Microbiol. Infect. 2015, 21, 591.e1–591.e10. [Google Scholar] [CrossRef]
  33. Adoubryn, K.D.; Kouadio-Yapo, C.G.; Ouhon, J.; Aka, N.A.; Bintto, F.; Assoumou, A. Parasitoses intestinales infantiles à Biankouma, région des 18 Montagnes (ouest de la Côte d’Ivoire): Étude de l’efficacité et de la tolérance du praziquantel et de l’albendazole. Med. Sante Trop. 2012, 22, 170–176. [Google Scholar] [PubMed]
  34. Becker, S.L.; Sieto, B.; Silué, K.D.; Adjossan, L.; Koné, S.; Hatz, C.; Kern, W.V.; N’Goran, E.K.; Utzinger, J. Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a co-endemic setting. PLoS Negl. Trop. Dis. 2011, 5, e1292. [Google Scholar] [CrossRef] [PubMed]
  35. Traore, S.G.; Odermatt, P.; Bonfoh, B.; Utzinger, J.; Aka, N.D.; Adoubryn, K.D.; Assoumou, A.; Dreyfuss, G.; Koussemon, M. No Paragonimus in high-risk groups in Côte d’Ivoire, but considerable prevalence of helminths and intestinal protozoon infections. Parasites Vectors 2011, 4, 96. [Google Scholar] [CrossRef]
  36. Djohan, V.; Yavo, W.; Barro-Kiki, P.C.; Vanga, A.H.; Kassi, K.F.; Konate, A.; Ouattara, M.; Menan, E.I.; Kone, M. Epidémiologie de l’anguillulose chez les enfants scolarisés à l’école publique à Abidjan (Côte d’Ivoire). Med. Trop. 2010, 70, 305–306. [Google Scholar]
  37. Diakite, N.R.; Adja, A.M.; von Stamm, T.; Utzinger, J.; N’Goran, E.K. Situation épidémiologique avant la mise en eau du barrage hydroagricole de cinq villages de Bouaké, centre Côte-d’Ivoire. Bull. Soc. Pathol. Exot. 2010, 103, 22–28. [Google Scholar] [CrossRef]
  38. Glinz, D.; Silué, K.D.; Knopp, S.; Lohourignon, L.K.; Yao, K.P.; Steinmann, P.; Rinaldi, L.; Cringoli, G.; N’Goran, E.K.; Utzinger, J. Comparing diagnostic accuracy of Kato-Katz, Koga Agar plate, ether-concentration, and FLOTAC for Schistosoma mansoni and soil-transmitted helminths. PloS Negl. Trop. Dis. 2010, 4, e754. [Google Scholar] [CrossRef]
  39. Glinz, D.; N’Guessan, N.A.; Utzinger, J.; N’Goran, E.K. High Prevalence of Strongyloides stercoralis among school children in rural Côte d’Ivoire. J. Parasitol. 2010, 96, 431–433. [Google Scholar] [CrossRef]
  40. Menan, E.I.; Kassi, F.K.; Yavo, W.; Djohan, V.; Vanga, H.; Barro, P.C.; Oga, S.S.; Konate, A.; Gbocho, F.Y.; Adjetey, T.A.; et al. Helminthoses intestinales chez les enfants d’âge scolaire de la zone rurale et urbaine de Tiassalé (Côte d’Ivoire). Med. Trop. (Mars) 2008, 68, 658–659. [Google Scholar]
  41. Evi, J.B.; Yavo, W.; Barro-Kiki, P.C.; Menan, E.H.I.; Koné, M. Helminthoses intestinales en milieu scolaire dans six villes du sud-ouest de la Côte d’Ivoire. Bull. Soc. Pathol. Exot. 2007, 100, 176–177. [Google Scholar]
  42. Yapi, Y.G.; Briet, O.J.; Vounatsou, P. Prevalence of geohelminths in savana and forest areas of Côte d’Ivoire. West. Afr. J. Med. 2006, 25, 124–125. [Google Scholar]
  43. Dancesco, P.; Abeu, J.; Akakpo, C.; Iamandi, I.; Kacou, E.; Quenou, F.; Keusse-Assi, J. Les parasitoses intestinales dans un village de Côte d’Ivoire. I: Essai de mise en place d’une stratégie de lutte et de prévention. Cahiers Santé 2005, 15, 5–10. [Google Scholar]
  44. Agbaya, S.S.; Yavo, W.; Menan, E.I.; Attey, M.A.; Kouadio, L.P.; Koné, M. Helminthiases intestinales chez les enfants d’âge scolaire: Résultats préliminaires d’une étude prospective à Agboville dans le sud de la Côte d’Ivoire. Sante 2004, 14, 143–147. [Google Scholar]
  45. Menan, E.I.H.; Nebavi, N.G.F.; Adjetey, T.A.K.; Assavo, N.N.; Kiki-Barro, P.C.; Koné, M. Profil des helminthiases intestinales chez les enfants d’âge scolaire dans la ville d’Abidjan. Bull. Soc. Pathol. Exot. 1997, 90, 51–54. [Google Scholar]
  46. Menan, E.I.H.; Nebavi, N.G.F.; Adjetey, T.A.K.; Assavo, N.N.; Deddy, B.A.N.; Barro-Kiki, P.C.; Koné, M. Influence des conditions socio-économiques sur la survenue des helminthiases intestinales: Étude réalisée chez 1001 enfants d’âge scolaire à Abidjan (Côte d’Ivoire). Cahiers Santé 1997, 7, 205–209. [Google Scholar] [PubMed]
  47. Therizol-Ferly, P.; Tagliante-Saracino, M.J.; Koné, M.; Konan, A.; Ouhon, J.; Assoumou, A.; Aka, K.; Assalé, G. Diarrhées chroniques et paratitoses chez des adultes suspectés de SIDA en Côte d’Ivoire. Bull. Soc. Pathol. Exot. Fil. 1989, 82, 690–693. [Google Scholar]
  48. Penali, K.L.; Koné, M.; Abrogoua, D.; Anick, S. Les helminthiases intestinales dans l’île d’ancien-Fresco (Côte-d’Ivoire). Bull. Soce Pathol. Exot. 1988, 81, 740–742. [Google Scholar]
  49. Haller, L.; Lauber, E. Santé de l’enfant d’âge scolaire en Cöte d’Ivoire. Acta Trop. 1980, 37 (Suppl. 11), 1–132. [Google Scholar]
  50. Nozais, J.P.; Doucet, J.; Dunand, J.; Lebras, M. Enquête coprologique chez des enfants bilharziens de la région d’Adzopé (Côte d’Ivoire). Bull. Soc. Pathol. Exot. 1975, 68, 73–79. [Google Scholar]
  51. Gbonhinbor, J.; Abah, A.E.; Awi-Waadu, G. Geo-mapping of intestinal parasitic infection in a southern community in Nigeria. Ethiop. J. Health Sci. 2024, 34, 203–210. [Google Scholar] [CrossRef]
  52. Agabi, Y.A.; Emeka Ezeife, C.E.; Uneze, S.B.; Okojokwu, O.J.; Eya, B.S.; Jude, N.; Zakari, H.; Isaac, M.A.; Adoga, M.P.; Owuna, J.E.; et al. Prevalence of intestinal helminths among HIV patients accessing healthcare services at Faith Alive Foundation, Jos, Nigeria. Microbes Infect. Dis. 2023, 4, 276–284. [Google Scholar] [CrossRef]
  53. Alade, T.; Ta-Tang, T.H.; Nassar, S.A.; Akindele, A.A.; Capote-Morales, R.; Omobami, T.B.; Berzosa, P. Prevalence of Schistosoma haematobium and intestinal helminth infections among Nigerian school children. Diagnostics 2023, 13, 759. [Google Scholar] [CrossRef]
  54. Imalele, E.E.; Braide, E.I.; Emanghe, U.E.; Effanga, E.O.; Usang, A.U. Soil-transmitted helminth infection among school-age children in Ogoja, Nigeria: Implication for control. Parasitol. Res. 2023, 122, 1015–1026. [Google Scholar] [CrossRef]
  55. Udeh, E.O.; Obiezue, R.N.; Ikele, C.B.; Otuu, C.A.; Okoye, I.C.; Eke, S.S.; Okafor, F.C.; Goselle, O.N.; Jwanle, P.; Iheanacho, N.S.; et al. Intestinal parasitic infections among HIV/AIDS Patients in relation to ART adherence in Nigeria. Niger. J. Parasitol. 2023, 441, 128–136. [Google Scholar] [CrossRef]
  56. Evbuomwan, I.O.; Edosomwan, E.U.; Idubor, V.; Bazuaye, C.; Abhulimhen-Iyoha, B.I.; Adeyemi, O.S.; Adeyemi, E.E. Survey of intestinal parasitism among schoolchildren in internally displaced persons camp, Benin City, Nigeria. Sci. Afr. 2022, 17, e01373. [Google Scholar] [CrossRef]
  57. Inah, I.O.; Otu-Bassey, I.B.; Udefa, A.L. Intestinal parasitosis and CD4 levels among cancer patients in Calabar, Nigeria. Afr. J. Biomed. Res. 2022, 25, 297–302. [Google Scholar]
  58. Nwankwo, A.; Onyebueke, A.C.; Irikannu, K.C.; Nzeukwu, C.I.; Onwuzulike, I.V.; Okafor, N.M. Soil-transmitted helminths infection and associated risk factors among primary school pupils in Omogho and Awa communities, Anambra State, Nigeria. Int. J. Trop. Dis. Health 2021, 42, 56–64. [Google Scholar] [CrossRef]
  59. Yaro, C.A.; Kogi, E.; Luka, S.A.; Nassan, M.A.; Kabir, J.; Opara, K.N.; Hetta, H.F.; Batiha, G.E. Edaphic and climatic factors influence on the distribution of soil transmitted helminths in Kogi East, Nigeria. Sci. Rep. 2021, 11, 8490. [Google Scholar] [CrossRef]
  60. Nnolim, C.; Adekeye, T.A.; Awobode, H.O. Intestinal helminth infection and malnutrition among public primary school children in Ibadan, Nigeria. Niger. J. Parasitol. 2020, 41, 49–55. [Google Scholar] [CrossRef]
  61. Abe, E.M.; Echeta, O.C.; Ombugadu, A.; Ajah, L.; Aimankhu, P.O.; Oluwole, A.S. Helminthiasis among school-age children and hygiene conditions of selected schools in Lafia, Nasarawa State, Nigeria. Trop. Med. Infect. Dis. 2019, 4, 112. [Google Scholar] [CrossRef]
  62. Dahal, A.S.; Francis, E.O.; Francis, J.E.; Wamtas, F.I. Soil-transmitted helminths and associated risk factors among elementary school pupils in Dadin Kowa, Jos. Niger. Med. J. 2019, 60, 181–185. [Google Scholar] [CrossRef]
  63. Dawaki, S.; Al-Mekhlafi, H.M.; Ithoi, I. The burden and epidemiology of polyparasitism among rural communities in Kano State, Nigeria. Trans. R. Soc. Trop. Med. Hyg. 2019, 113, 169–182. [Google Scholar] [CrossRef]
  64. Udeh, E.O.; Obiezue, R.N.N.; Okafor, F.C.; Ikele, C.B.; Okoye, I.C.; Otuu, C.A. Gastrointestinal parasitic infections and immunological status of HIV/AIDS coinfected individuals in Nigeria. Ann. Glob. Health 2019, 85, 99. [Google Scholar] [CrossRef]
  65. Ayede, A.I.; Bello, F.A.; Kehinde, A.O. A community-based surveillance of gastrointestinal helminthiasis among pregnant women in Ibadan, South West Nigeria. Niger. J. Clin. Pract. 2018, 21, 1368–1373. [Google Scholar]
  66. Akinbo, F.; Akanbi, T. Enteric parasitic infections amongst cement masons in Benin City, Edo State, Nigeria. Niger. J. Health Sci. 2018, 16, 82–85. [Google Scholar] [CrossRef]
  67. Amoo, J.K.; Akindele, A.A.; Amoo, A.O.J.; Efunshile, A.M.; Ojurongbe, T.A.; Fayemiwo, S.A.; Thomas, B.N.; Ojurongbe, O. Prevalence of enteric parasitic infections among people living with HIV in Abeokuta, Nigeria. Pan Afr. Med. J. 2018, 30, 66. [Google Scholar] [CrossRef]
  68. Gbebi, Y.V.; Jafaaru, A.; Elkanah, O.S.; Chintem, D.G.W.; Njilmah, J.A.; Jonathan, J.; Tese, T. Prevalence of gastrointestinal helminths infections among school-aged children in Kurmi Local Government Area, Taraba State, Nigeria. Niger. J. Parasitol. 2018, 39, 55–60. [Google Scholar] [CrossRef]
  69. Ojurongbe, O.; Okorie, P.N.; Opatokun, R.L.; Ojurongbe, T.A.; Mabayoje, V.O.; Olowe, O.A.; Adeyeba, O.A. Prevalence and associated factors of Plasmodium falciparum and soil transmitted helminth infections among pregnant women in Osun state, Nigeria. Afr. Health Sci. 2018, 18, 542–551. [Google Scholar] [CrossRef]
  70. Adeniran, A.A.; Mogaji, H.O.; Aladesida, A.A.; Olayiwola, I.O.; Oluwole, A.S.; Abe, E.M.; Olabinke, D.B.; Alabi, O.M.; Ekpo, U.F. Schistosomiasis, intestinal helminthiasis and nutritional status among preschool-aged children in sub-urban communities of Abeokuta, Southwest, Nigeria. BMC Res. Notes 2017, 10, 637. [Google Scholar] [CrossRef]
  71. Inyang-Etoh, P.C.; Agorye, A.H.; Okpokam, D.C.; Opara-Osuoha, U. Prevalence of malaria and intestinal parasites coinfections and their effects on haemoglobin levels among school aged children in Bebuatsuan clan, Obudu, cross River State, Nigeria. J. Med. Allied Sci. 2017, 7, 92–98. [Google Scholar]
  72. Ivoke, N.; Ikpor, N.; Ivoke, O.; Ekeh, F.; Ezenwaji, N.; Odo, G.; Iyaji, F.; Onoja, U.; Eyo, J. Geophagy as risk behaviour for gastrointestinal nematode infections among pregnant women attending antenatal clinics in a humid tropical zone of Nigeria. Afr. Health Sci. 2017, 17, 24–31. [Google Scholar] [CrossRef]
  73. Muazu, I.; Abdullahi, Y.; Umar, Z. Prevalence of human intestinal parasitic nematode among out-patients attending wudil general hospital, kano state, Nigeria. Ann. Trop. Med. Public Health 2017, 6, 1–5. [Google Scholar]
  74. Shitta, K.B.; Akogun, O.B. Intestinal helminth infections among the nomadic Fulanis in two localities of Adamawa State, North-East Nigeria. Niger. J. Parasitol. 2017, 38, 69–73. [Google Scholar] [CrossRef]
  75. Taiwo, O.T.; Sam-Wobo, S.O.; Idowu, O.A.; Talabi, A.O.; Taiwo, A.M. Comparative assessment of intestinal helminths prevalence in water, sanitation and hygiene (WASH) intervention and non-intervention communities in Abeokuta, Nigeria. Asian Pac. J. Trop. Biomed. 2017, 7, 524–532. [Google Scholar] [CrossRef]
  76. Douglas, K.E.; Amadi, C.U. Soil transmitted helminth infection among farmers in Ukwa West Local Government Area, Abia State, south-east, Nigeria. Niger. J. Med. 2016, 25, 24–32. [Google Scholar] [CrossRef]
  77. Obateru, O.A.; Bojuwoye, B.J.; Olokoba, A.B.; Fadeyi, A.; Fowotade, A.; Olokoba, L.B. Prevalence of intestinal parasites in newly diagnosed HIV/AIDS patients in Ilorin, Nigeria. Alex. J. Med. 2016, in press. [CrossRef]
  78. Abah, A.E.; Arene, F.O.I. Status of intestinal parasitic infections among primary school children in rivers state, Nigeria. J. Parasitol. Res. 2015, 2015, 937096. [Google Scholar] [CrossRef]
  79. Agu, P.U.; Ogboi, J.S.; Akpoigbe, K.; Okeke, T.; Ezugwu, E. Impact of Plasmodium falciparum and hookworm infections on the frequency of anaemia in pregnant women of rural communities in Enugu, South East Nigeria. Pan Afr. Med. J. 2013, 14, 27. [Google Scholar]
  80. Ohaeri, C.C.; Orji, N.B. Intestinal parasites among undergraduate students of Michael Okpara university of agriculture, Umudike Abia state, Nigeria. World Appl. Sci. J. 2013, 25, 1171–1173. [Google Scholar]
  81. Abaver, D.T.; Nwobegahay, J.M.; Goon, D.T.; Iweriebor, B.C.; Khoza, L.B. Enteric parasitic infections in HIV-infected patients with low CD4 counts in Toto, Nigeria. Pak. J. Med. Sci. 2012, 28, 630–633. [Google Scholar]
  82. Akinbo, F.O.; Okaka, C.E.; Omoregie, R. Plasmodium falciparum and intestinal parasitic co-infections in HIV-infected patients in Benin City, Edo State, Nigeria. J. Infect. Dev. Ctries. 2012, 6, 430–435. [Google Scholar] [CrossRef]
  83. Oguanya, F.C.; Okogun, G.R.A.; Akhile, A.O.; Eloka, C.C.V.; Okoro, C.J.; Okpe, A.C. Prevalence of soil-transmitted helminths infections among public primary school pupils in Ekpoma, Edo State, Nigeria. Int. J. Community Res. 2012, 1, 30–34. [Google Scholar]
  84. Abaver, D.T.; Nwobegahay, J.M.; Goon, D.T.; Iweriebor, B.C.; Anye, D.N. Prevalence of intestinal parasitic infections among HIV/AIDS patients from two health institutions in Abuja, Nigeria. Afr. Health Sci. 2011, 11 (Suppl. 1), 24–27. [Google Scholar]
  85. Akinbo, F.O.; Okaka, C.E.; Omoregie, R. Seasonal variation of intestinal parasitic infections among HIV-positive patients in Benin City, Nigeria. Ethiop. J. Health Sci. 2011, 21, 191–194. [Google Scholar]
  86. Akinbo, F.O.; Okaka, C.E.; Omoregie, R. Prevalence of intestinal parasites in relation to CD4 counts and anaemia among HIV-infected patients in Benin City, Edo State, Nigeria. Tanzan. J. Health Res. 2011, 13, 8–13. [Google Scholar] [CrossRef]
  87. Akinbo, F.O.; Omoregie, R. Intestinal parasitic infections in human immunodeficiency- virus-infected persons on highly active antiretroviral therapy in Benin City, Nigeria. Genom. Med. Biomarkers Health Sci. 2011, 3, 119–122. [Google Scholar] [CrossRef]
  88. Sanyaolu, A.O.; Oyibo, W.A.; Fagbenro-Beyioku, A.F.; Gbadegeshin, A.H.; Iriemenam, N.C. Comparative study of entero-parasitic infections among HIV sero-positive and sero-negative patients in Lagos, Nigeria. Acta Trop. 2011, 120, 268–272. [Google Scholar] [CrossRef]
  89. Babatunde, S.K.; Salami, A.K.; Fabiyi, J.P.; Agbede, O.O.; Desalu, O.O. Prevalence of intestinal parasitic infestation in HIV seropositive and seronegative patients in Ilorin, Nigeria. Ann. Afr. Med. 2010, 9, 123–128. [Google Scholar] [CrossRef]
  90. Dada-Adegbola, H.O.; Oluwatoba, O.A.; Bakaré, R.A. Strongyloidiasis: Prevalence, risk factors, clinical and laboratory features among diarrhea patients in Ibadan Nigeria. Afr. J. Med. Med. Sci. 2010, 39, 285–292. [Google Scholar]
  91. Damen, J.G.; Lar, P.; Mershak, P.; Mbaawuga, E.M.; Nyary, B.W. A Comparative study on the prevalence of intestinal helminthes in dewormed and non-dewormed students in a rural area of north-central Nigeria. Lab. Med. 2010, 41, 585–589. [Google Scholar] [CrossRef]
  92. Umar, A.A.; Bassey, S.E. Incidence of Strongyloides stercoralis infection in Ungogo, Nassarawa, Dala and Fagge local government areas of Kano State, Nigeria. Bayero J. Pure Appl. Sci. 2010, 3, 76–80. [Google Scholar] [CrossRef]
  93. Houmsou, R.S.; Amuta, E.; Olusi, T. Prevalence of intestinal parasites among primary school children in Makurdi, Benue State- Nigeria. Int. J. Infect. Dis. 2009, 8, 80–86. [Google Scholar]
  94. Morenikeji, O.A.; Azubike, N.C.; Ige, A.O. Prevalence of intestinal and vector-borne urinary parasites in communities in south-west Nigeria. J. Vector Borne Dis. 2009, 46, 164–167. [Google Scholar]
  95. Ibidapo, C.A.; Okwa, O. The prevalence and intensity of soil-transmitted helminths in a rural community, Lagos Suburb, southwest Nigeria. Int. J. Agric. Biol. 2008, 10, 89–92. [Google Scholar]
  96. Adeoye, G.O.; Osayemi, C.O.; Oteniya, O.; Onyemekeihia, S.O. Epidemiological studies of intestinal helminthes and malaria among children in Lagos, Nigeria. Pak. J. Biol. Sci. 2007, 10, 2208–2212. [Google Scholar] [CrossRef]
  97. Agbolade, O.M.; Agu, N.C.; Adesanya, O.O.; Odejayi, A.O.; Adigun, A.A.; Adesanlu, E.B.; Ogunleye, F.G.; Sodimu, A.O.; Adeshina, S.A.; Bisiriyu, G.O.; et al. Intestinal helminthiases and schistosomiasis among school children in an urban center and some rural communities in southwest Nigeria. Korean J. Parasitol. 2007, 45, 233–238. [Google Scholar] [CrossRef]
  98. Ikeh, E.I.; Obadofin, M.O.; Brindeiro, B.; Baugherb, C.; Frost, F.; Vanderjagt, D.; Glew, R.H. Intestinal parasitism in Magama Gumau rural village and Jos township in north central Nigeria. Niger. Postgrad. Med. J. 2007, 14, 290–295. [Google Scholar] [CrossRef]
  99. Ugbomoiko, U.S.; Ofoezie, I.E. Multiple infection diagnosis of intestinal helminthiasis in the assessment of health and environmental effect of development projects in Nigeria. J. Helminthol. 2007, 81, 227–231. [Google Scholar] [CrossRef]
  100. Wagbatsoma, V.A.; Aisien, M.S. Helminthiasis in selected children seen at the University of Benin Teaching Hospital (UBTH), Benin City, Nigeria. Niger. Postgrad. Med. J. 2005, 12, 23–27. [Google Scholar] [CrossRef]
  101. Anosike, J.C.; Nwoke, B.E.; Onwuliri, C.O.; Obiukwu, C.E.; Duru, A.F.; Nwachukwu, M.I.; Ukaga, C.N.; Uwaezuoke, J.C.; Uduji, O.S.; Amajuoyi, O.U.; et al. Prevalence of parasitic diseases among nomadic Fulanis of south-eastern Nigeria. Ann. Agric. Environ. Med. 2004, 11, 221–225. [Google Scholar]
  102. Dada-Adegbola, H.O.; Bakare, R.A. Strongyloidiasis in children five years and below. West. Afr. J. Med. 2004, 23, 194–197. [Google Scholar] [CrossRef]
  103. Anyaeze, C.M. Reducing burden of hookworm disease in the management of upper abdominal pain in the tropics. Trop. Doct 2003, 33, 174–175. [Google Scholar] [CrossRef]
  104. Okoronkwo, M.O. Parasitic infections of dry season farmers in some parts of Plateau State, Nigeria. Afr. J. Clin. Exp. Microbiol. 2002, 3, 104–110. [Google Scholar] [CrossRef]
  105. Ozumba, U.C.; Ozumba, N. Patterns of helminth infection in the human gut at the University of Nigeria Teaching Hospital, Enugu, Nigeria. J. Health Sci. 2002, 48, 263–268. [Google Scholar] [CrossRef]
  106. Nwokediuko, S.; Bababode, B.; Chinedu, O.U.; Ozoh, G. Peculiarities of chronic diarrhoea in Enugu, Southeastern Nigeria. J. Health Sci. 2002, 48, 435–440. [Google Scholar] [CrossRef]
  107. Nwaorgu, O.C.; Okeibunor, J.; Madu, E.; Amazigo, U.; Onyegegbu, N.; Evans, D. A school-based schistosomiasis and intestinal helminthiasis control programme in Nigeria: Acceptability to community members. Trop. Med. Int. Health 1998, 3, 842–849. [Google Scholar] [CrossRef]
  108. Sodipo, J.O.; Padgett, D.; Warrie, E.; Olopoenia, L. Parasitic infections in sickle cell crisis: Nigerian experience. J. Natl. Med. Assoc. 1997, 89, 285–288. [Google Scholar]
  109. Udonsi, J.K.; Behnke, J.M.; Gilbert, F.S. Analysis of the prevalence of infection and associations between human gastrointestinal nematodes among different age classes living in the urban and suburban communities of Port Harcourt, Nigeria. J. Helminthol. 1996, 70, 75–84. [Google Scholar] [CrossRef]
  110. Asaolu, S.O.; Holland, C.V.; Jegede, J.O.; Fraser, N.R.; Stoddard, R.C.; Crompton, D.W.T. The prevalence and intensity of soil-transmitted helminthiases in rural communities in southern Nigeria. Ann. Trop. Med. Parasitol. 1992, 86, 279–287. [Google Scholar] [CrossRef]
  111. Akogun, O.B. Some social aspects of helminthiasis among the people of Gumau District, Bauchi State, Nigeria. J. Trop. Med. Hyg. 1989, 92, 193–196. [Google Scholar]
  112. Holland, C.V.; Asaolu, S.O.; Crompton, D.W.; Stoddart, R.C.; Macdonald, R.; Torimiro, S.E. The epidemiology of Ascaris lumbricoides and other soil-transmitted helminths in primary school children from Ile-Ife, Nigeria. Parasitology 1989, 99 Pt 2, 275–285. [Google Scholar] [CrossRef]
  113. Arene, F.O. Preliminary parasitological survey of intestinal parasites among inhabitants of Okrika Island in the Niger Delta. J. Infect. 1984, 9, 309–310. [Google Scholar] [CrossRef]
  114. Backhaus, J.; Kann, S.; Hahn, A.; Weinreich, F.; Blohm, M.; Tanida, K.; Feldt, T.; Sarfo, F.S.; Di Cristanziano, V.; Loderstädt, U.; et al. Clustering of gastrointestinal microorganisms in human stool samples from Ghana. Pathogens 2024, 13, 583. [Google Scholar] [CrossRef]
  115. Deku, J.G.; Okyere, D.O.; Buabeng, S.; Edziah, F.S.; Bedzina, I.; Kinanyok, S.; Duedu, K.O.; Aninagyei, E. The burden and trend of intestinal parasitosis among women at Berekum, Ghana: A 9-year retrospective study. BMC Infect. Dis. 2024, 24, 1287. [Google Scholar] [CrossRef]
  116. Donkoh, E.T.; Berkoh, D.; Fosu-Gyasi, S.; Boadu, W.I.O.; Raji, A.S.; Asamoah, S.; Otabil, K.B.; Otoo, J.E.; Yeboah, M.T.; Aganbire, B.A.; et al. Evidence of reduced academic performance among schoolchildren with helminth infection. Int. Health 2023, 15, 309–317. [Google Scholar] [CrossRef]
  117. Akenten, C.W.; Weinreich, F.; Paintsil, E.K.; Amuasi, J.; Fosu, D.; Loderstadt, U.; May, J.; Frickmann, H.; Dekker, D. Intestinal helminth infections in Ghanaian children from the Ashanti Region between 2007 and 2008-a retrospective cross-sectional real-time PCR-based assessment. Trop. Med. Infect. Dis. 2022, 7, 374. [Google Scholar] [CrossRef]
  118. Fornace, K.M.; Senyonjo, L.; Martin, D.L.; Gwyn, S.; Schmidt, E.; Agyemang, D.; Marfo, B.; Addy, J.; Mensah, E.; Solomon, A.W.; et al. Characterising spatial patterns of neglected tropical disease transmission using integrated sero-surveillance in Northern Ghana. PLoS Negl. Trop. Dis. 2022, 16, e0010227. [Google Scholar] [CrossRef]
  119. Aninagyei, E.; Yirenkyi, R.; Rufai, T.; Chandi, M.G. Enteroparasitism in hard-to-reach community dwellers: A cross-sectional study in Ga West municipality in Ghana. J. Parasitol. Res. 2020, 2020, 8890998. [Google Scholar] [CrossRef]
  120. Cunningham, L.J.; Campbell, S.J.; Armoo, S.; Koukounari, A.; Watson, V.; Selormey, P.; Stothard, J.R.; Idun, B.; Asiedu, M.; Ashong, Y.; et al. Assessing expanded community wide treatment for schistosomiasis: Baseline infection status and self-reported risk factors in three communities from the Greater Accra region, Ghana. PLoS Negl. Trop. Dis. 2020, 14, e0007973. [Google Scholar] [CrossRef]
  121. Kpene, G.E.; Lokpo, S.Y.; Deku, J.G.; Agboli, E.; Owiafe, P.K. Asymptomatic intestinal parasitic infestations among children under five years in selected communities in the Ho municipality, Ghana. Ethiop. J. Health Sci. 2020, 30, 867–874. [Google Scholar] [CrossRef]
  122. Adu-Gyasi, D.; Asante, K.P.; Frempong, M.T.; Gyasi, D.K.; Iddrisu, L.F.; Ankrah, L.; Dosoo, D.; Adeniji, E.; Agyei, O.; Gyaase, S.; et al. Epidemiology of soil transmitted helminth infections in the middle-belt of Ghana, Africa. Parasite Epidemiol. Control 2018, 3, e00071. [Google Scholar] [CrossRef] [PubMed]
  123. Cunningham, L.J.; Odoom, J.; Pratt, D.; Boatemaa, L.; Asante-Ntim, N.; Attiku, K.; Banahene, B.; Osei-Atweneboana, M.; Verweij, J.J.; Molyneux, D.; et al. Expanding molecular diagnostics of helminthiasis: Piloting use of the GPLN platform for surveillance of soil transmitted helminthiasis and schistosomiasis in Ghana. PLoS Negl. Trop. Dis. 2018, 12, e0006129. [Google Scholar] [CrossRef] [PubMed]
  124. Forson, A.O.; Arthur, I.; Olu-Taiwo, M.; Glover, K.K.; Pappoe-Ashong, P.J.; Ayeh-Kumi, P.F. Intestinal parasitic infections and risk factors: A cross-sectional survey of some school children in a suburb in Accra, Ghana. BMC Res. Notes 2017, 10, 485. [Google Scholar] [CrossRef]
  125. Tay, S.C.K.; Nani, E.A.; Walana, W. Parasitic infections and maternal anaemia among expectant mothers in the Dangme east district of Ghana. BMC Res. Notes 2017, 10, 3. [Google Scholar] [CrossRef]
  126. Agboli, E.; Tay, S.C.K.; Obirikorang, C.; Aidoo, E.Y. Malaria and intestinal parasites in pregnant and non-pregnant women: A comparative study at the University Hospital, Kumasi, Ghana. J. Med. Biomed. Sci. 2015, 4, 31–35. [Google Scholar] [CrossRef]
  127. Danikuu, F.M.; Azikala, O.; Baguo, F.M. Faeco-oral parasitic infection in street food vendors in Tamale, Ghana. J. Med. Biomed. Sci. 2015, 4, 7–13. [Google Scholar] [CrossRef]
  128. Duedu, K.O.; Karikari, Y.A.; Attah, S.K.; Ayeh-Kumi, P.F. Prevalence of intestinal parasites among patients of a Ghanaian psychiatry hospital. BMC Res. Notes 2015, 8, 651. [Google Scholar] [CrossRef]
  129. Tay, S.C.K.; Gbedema, S.Y.; Gyampomah, T.K. High prevalence of hookworm infection and apparent absence of Ascaris lumbricoides: A case study at the Komfo Anokye Teaching Hospital in Ghana. Int. J. Pharm. Sci. Res. 2011, 5, 1217–1224. [Google Scholar]
  130. Baidoo, S.E.; Tay, S.C.K.; Obiri-Danso, K.; Abruquah, H.H. Intestinal helminth infection and anaemia during pregnancy: A community based study in Ghana. J. Bacteriol. Res. 2010, 2, 9–13. [Google Scholar]
  131. Yatich, N.J.; Jolly, P.E.; Funkhouser, E.; Agbenyega, T.; Rayner, J.C.; Ehiri, J.E.; Turpin, A.; Stiles, J.K.; Ellis, W.O.; Jiang, Y.; et al. The effect of malaria and intestinal helminth coinfection on birth outcomes in Kumasi, Ghana. Am. J. Trop. Med. Hyg. 2010, 82, 28–34. [Google Scholar] [CrossRef]
  132. Verweij, J.J.; Canales, M.; Polman, K.; Ziem, J.; Brienen, E.A.; Polderman, A.M.; van Lieshout, L. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans. R. Soc. Trop. Med. Hyg. 2009, 103, 342–346. [Google Scholar] [CrossRef] [PubMed]
  133. Yatich, N.J.; Yi, J.; Agbenyega, T.; Turpin, A.; Rayner, J.C.; Stiles, J.K.; Ellis, W.O.; Funkhouser, E.; Ehiri, J.E.; Williams, J.H.; et al. Malaria and intestinal helminth co-infection among pregnant women in Ghana: Prevalence and risk factors. Am. J. Trop. Med. Hyg. 2009, 80, 896–901. [Google Scholar] [CrossRef] [PubMed]
  134. Yelifari, L.; Bloch, P.; Magnussen, P.; van Lieshout, L.; Dery, G.; Anemana, S.; Agongo, E.; Polderman, A.M. Distribution of human Oesophagostomum bifurcum, hookworm and Strongyloides stercoralis infections in northern Ghana. Trans. R. Soc. Trop. Med. Hyg. 2005, 99, 32–38. [Google Scholar] [CrossRef] [PubMed]
  135. Annan, A.; Crompton, D.W.; Walters, D.E.; Arnold, S.E. An investigation of the prevalence of intestinal parasites in pre-school children in Ghana. Parasitology 1986, 92, 209–217. [Google Scholar] [CrossRef]
  136. Boko, P.M.; Ibikounle, M.; Onzo-Aboki, A.; Tougoue, J.J.; Sissinto, Y.; Batcho, W.; Kinde-Gazard, D.; Kabore, A. Schistosomiasis and soil transmitted helminths distribution in Benin: A baseline prevalence survey in 30 districts. PLoS ONE 2016, 11, e0162798. [Google Scholar] [CrossRef]
  137. Ibikounle, M.; Gbedjissi, L.G.; Ogouyemi-Hounto, A.; Batcho, W.; Kinde-Gazard, D.; Massougbodji, A. Schistosomose et géohelminthoses dans le nord-est du Bénin: Cas des écoliers des communes de Nikki et de Pèrèrè. Bull. Soc. Pathol. Exot. 2014, 107, 171–176. [Google Scholar] [CrossRef]
  138. Chippaux, J.P.; Massougbodji, A.; Zomadi, A.; Kindafodji, B.M. Etude épidémiologique des schistosomes dans un complexe lacustre côtier de formation récente. Bull. Soc. Pathol. Exot. 1990, 83, 498–508. [Google Scholar]
  139. Ba, O.; Sy, O.; Mbareck, A.M.; Issa, S.M.; Fofana, M.; Baba, W.S. Epidemiology of intestinal parasitosis in schoolchildren in the Moughatâa of Riyadh (Nouakchott). Tunis. Med. 2024, 102, 671–676. [Google Scholar] [CrossRef]
  140. Urbani, C.; Touré, A.; Hamed, A.O.; Albonico, M.; Kane, I.; Cheikna, D.; Hamed, N.O.; Montresor, A.; Savioli, L. Parasitoses intestinales et schistosomiases dans la vallée du fleuve Sénégal en République Islamique de Mauritanie. Med. Trop. 1997, 57, 157–160. [Google Scholar]
  141. WHO. Intestinal parasitic infections and schistosomiasis. Wkly. Epidemiol. Rec. 1995, 30, 217–218. [Google Scholar]
  142. Diongue, K.; Ndiaye, M.; Seck, M.C.; Diallo, M.A.; Ndiaye, Y.D.; Badiane, A.S.; Ndiaye, D. Distribution of parasites detected in stool samples of patients in Le Dantec University Hospital of Dakar, Senegal, from 2011 to 2015. J. Trop. Med. 2017, 2017, 8296313. [Google Scholar] [CrossRef]
  143. Sow, D.; Parola, P.; Sylla, K.; Ndiaye, M.; Delaunay, P.; Halfon, P.; Camiade, S.; Dieng, T.; Tine, R.C.K.; Faye, B.; et al. Performance of real-time polymerase chain reaction assays for the detection of 20 gastrointestinal parasites in clinical samples from Senegal. Am. J. Trop. Med. Hyg. 2017, 97, 173–182. [Google Scholar] [CrossRef]
  144. Ndiaye, D.; Ndiaye, M.; Gueye, P.A.; Badiane, A.; Fall, I.D.; Ndiaye, Y.D.; Faye, B.; Ndiaye, J.L.; Tine, R.; Ndir, O. Prévalence des helminthoses digestives diagnostiquées à l’hôpital Le Dantec de Dakar, Sénégal. Med. Sante Trop. 2013, 23, 35–38. [Google Scholar]
  145. Salem, G.; van de Velden, L.; Laloe, F.; Maire, B.; Ponton, A.; Traissac, P.; Prost, A. Parasitoses intestinales et environnement dans les villes sahélo-soudaniennes: l’exemple de Pikine (Sénégal). Rev. Epidemiol. Sante Publique 1994, 42, 322–333. [Google Scholar]
  146. Mouchet, F.; Develoux, M.; Balla Magassa, M.; Sellin, B. Etude epidémiologique du foyer à Schistosoma mansoni Bana (Niger). Med. Trop. 1988, 48, 209–213. [Google Scholar]
  147. Sangaré, I.; Guiguemde, K.T.; Zida, A.; Sirima, C.; Sawadogo, P.M.; Cisse, M.; Assogba, S.B.; Guiguemde, T.R.; Bamba, S. Prevalence of intestinal parasitic infections among pregnant women in Bobo-Dioulasso (Burkina Faso). Ann. Parasitol. 2021, 67, 489–497. [Google Scholar]
  148. Sangaré, I.; Bamba, S.; Cissé, M.; Zida, A.; Bamogo, R.; Sirima, C.; Yameogo, B.K.; Sanou, R.; Drabo, F.; Dabire, R.K.; et al. Prevalence of intestinal opportunistic parasites infections in the University hospital of Bobo-Dioulasso, Burkina Faso. Infect. Dis. Poverty 2015, 4, 32. [Google Scholar] [CrossRef]
  149. Karou, S.D.; Sanou, D.; Ouermi, D.; Pignatelli, S.; Pietra, V.; Moret, R.; Nikiema, J.B.; Simpore, J. Enteric parasites prevalence at Saint Camille Medical Centre in Ouagadougou, Burkina Faso. Asian Pac. J. Trop. Med. 2011, 4, 401–403. [Google Scholar] [CrossRef] [PubMed]
  150. Buonfrate, D.; Bradbury, R.S.; Watts, M.R.; Bisoffi, Z. Human strongyloidiasis: Complexities and pathways forward. Clin. Microbiol. Rev. 2023, 36, e0003323. [Google Scholar] [CrossRef] [PubMed]
  151. Lo, N.C.; Addiss, D.G.; Buonfrate, D.; Amor, A.; Anegagrie, M.; Bisoffi, Z.; Bradbury, R.S.; Keiser, J.; Kepha, S.; Khieu, V.; et al. Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasis. Lancet Infect. Dis. 2025, 25, e146–e152. [Google Scholar] [CrossRef] [PubMed]
  152. Ramos, J.A.T.; Maure, T.; Carias, L.; Lew, D.; Goss, C.; Samuel, A.; Tavul, L.; Fischer, P.U.; Weil, G.J.; Laman, M.; et al. Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and infections in Papua New Guinea. PloS Negl. Trop. Dis. 2025, 19, e0012851. [Google Scholar]
  153. Tamarozzi, F.; Guevara, A.G.; Anselmi, M.; Vicuna, Y.; Prandi, R.; Marquez, M.; Vivero, S.; Robinzon Huerlo, F.; Racines, M.; Mazzi, C.; et al. Accuracy, acceptability, and feasibility of diagnostic tests for the screening of Strongyloides stercoralis in the field (ESTRELLA): A cross-sectional study in Ecuador. Lancet Glob. Health 2023, 11, e740–e748. [Google Scholar] [CrossRef] [PubMed]
  154. Malaga, J.L.; Fernandez-Baca, M.V.; Castellanos-Gonzalez, A.; Tanabe, M.B.; Tift, C.; Morales, M.L.; Lopez, M.; Valdivia-Rodriguez, A.; Mamani-Licona, F.; Cabada, M.M. The recombinase polymerase amplification test for Strongyloides stercoralis is more sensitive than microscopy and real-time PCR in high-risk communities of Cusco, Peru. Pathogens 2024, 13, 869. [Google Scholar] [CrossRef] [PubMed]
  155. Chankongsin, S.; Wampfler, R.; Ruf, M.T.; Odermatt, P.; Marti, H.; Nickel, B.; Keoluangkhot, V.; Neumayr, A. Strongyloides stercoralis prevalence and diagnostics in Vientiane, Lao People’s Democratic Republic. Infect. Dis. Poverty 2020, 9, 133. [Google Scholar] [CrossRef]
  156. Hailegebriel, T.; Petros, B.; Endeshaw, T. Evaluation of parasitological methods for the detection of Strongyloides Stercoralis among individuals in selected health institutions in Addis Ababa, Ethiopia. Ethiop. J. Health Sci. 2017, 27, 515–522. [Google Scholar] [CrossRef]
  157. de Alegria, M.; Colmenares, K.; Espasa, M.; Amor, A.; Lopez, I.; Nindia, A.; Kanjala, J.; Guilherme, D.; Sulleiro, E.; Barriga, B.; et al. Prevalence of Strongyloides stercoralis and other intestinal parasite infections in school children in a rural area of Angola: A cross-sectional study. Am. J. Trop. Med. Hyg. 2017, 97, 1226–1231. [Google Scholar] [CrossRef]
  158. Hailu, T.; Amor, A.; Nibret, E.; Munshea, A.; Anegagrie, M.; Flores-Chavez, M.D.; Tang, T.T.; Saugar, J.M.; Benito, A. Evaluation of five diagnostic methods for Strongyloides stercoralis infection in Amhara National Regional State, northwest Ethiopia. BMC Infect. Dis. 2022, 22, 297. [Google Scholar] [CrossRef]
  159. Amor, A.; Rodriguez, E.; Saugar, J.M.; Arroyo, A.; Lopez-Quintana, B.; Abera, B.; Yimer, M.; Yizengaw, E.; Zewdie, D.; Ayehubizu, Z.; et al. High prevalence of Strongyloides stercoralis in school-aged children in a rural highland of north-western Ethiopia: The role of intensive diagnostic work-up. Parasites Vectors 2016, 9, 617. [Google Scholar] [CrossRef]
  160. Eamudomkarn, C.; Sithithaworn, P.; Kamamia, C.; Yakovleva, A.; Sithithaworn, J.; Kaewkes, S.; Techasen, A.; Loilome, W.; Yongvanit, P.; Wangboon, C.; et al. Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. PLoS ONE 2018, 13, e0192598. [Google Scholar] [CrossRef]
  161. Plaisier, A.P.; Alley, E.S.; Boatin, B.A.; Van Oortmarssen, G.J.; Remme, H.; De Vias, S.J.; Bonneux, L.; Habbema, J.D.F. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the onchocerciasis control programme in West Africa. J. Infect. Dis. 1995, 172, 204–210. [Google Scholar] [CrossRef]
  162. Sawadogo, A.; Zoungrana, J.; Ouédraogo, A.G.; Diallo, I.; Tassembedo, M.; Kima, A.; Sermé, M.; Ouédraogo, B.; Tanon, A.K.; Eholié, S.P. Impact of mass drug administration of ivermectin and albendazole on transmission of Wuchereria bancrofti lymphatic filariasis from 2001 to 2017 in Burkina Faso. Trop. Med. Int. Health 2025, 30, 633–639. [Google Scholar] [CrossRef]
  163. Koroma, A.S.; Conteh, S.G.; Bah, M.; Kamara, H.I.; Turay, M.; Kandeh, A.; Macauley, A.; Allieu, H.; Kargbo, A.A.; Sonnie, M.; et al. Routine vitamin A supplementation and other high impact interventions in Sierra Leone. Matern. Child. Nutr. 2020, 16, e13041. [Google Scholar] [CrossRef]
Figure 1. Flow diagram of studies pertaining to Strongyloides stercoralis infection in West Africa from 1975 to 2024 for the systematic review and meta-analysis.
Figure 1. Flow diagram of studies pertaining to Strongyloides stercoralis infection in West Africa from 1975 to 2024 for the systematic review and meta-analysis.
Tropicalmed 10 00321 g001
Figure 2. Number of publications pertaining to Strongyloides stercoralis infection in West Africa from 1975 to 2024. The red lines indicate the decadal limits.
Figure 2. Number of publications pertaining to Strongyloides stercoralis infection in West Africa from 1975 to 2024. The red lines indicate the decadal limits.
Tropicalmed 10 00321 g002
Figure 3. Dynamic of Strongyloides stercoralis infection prevalence in community-, hospital-, and school-based studies in West Africa from 1975 to 2024. n: Number of participants.
Figure 3. Dynamic of Strongyloides stercoralis infection prevalence in community-, hospital-, and school-based studies in West Africa from 1975 to 2024. n: Number of participants.
Tropicalmed 10 00321 g003
Figure 4. Number and percentage of individual studies using specific diagnostic tests for the detection of Strongyloides stercoralis infection in West Africa from 1975 to 2024. DA: direct analysis, FE: formol-ether, KK: Kato-Katz, MBA: multiplex bead assay, SAAF: sodium acetic acid formalin.
Figure 4. Number and percentage of individual studies using specific diagnostic tests for the detection of Strongyloides stercoralis infection in West Africa from 1975 to 2024. DA: direct analysis, FE: formol-ether, KK: Kato-Katz, MBA: multiplex bead assay, SAAF: sodium acetic acid formalin.
Tropicalmed 10 00321 g004
Figure 5. Prevalence of Strongyloides stercoralis infection in West African countries between 1975 and 2024.
Figure 5. Prevalence of Strongyloides stercoralis infection in West African countries between 1975 and 2024.
Tropicalmed 10 00321 g005
Figure 6. (A) Prevalence of Strongyloides stercoralis infection in Nigeria [51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113]. (B) Prevalence of Strongyloides stercoralis infection in Côte d’Ivoire [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50]. (C) Prevalence of Strongyloides stercoralis infection ienin [136,137,138]. (D) Prevalence of Strongyloides stercoralis infection in Ghana, Mauritania, and The Gambia [12,13,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,139,140,141]. (E) Prevalence of Strongyloides stercoralis infection in Burkina Faso, Cape Verde, Guinea, Guinea-Bissau, Liberia, Niger, Senegal, Sierra Leone, and Togo [14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,141,142,143,144,145,146,147,148]. Grey square represents the weight of each study in the meta-analysis. The blue diamond displays overall or subtotal pooled prevalence of S. stercoralis infection. The width of the diamond shows the 95% CI of the pooled prevalence of the infection.
Figure 6. (A) Prevalence of Strongyloides stercoralis infection in Nigeria [51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113]. (B) Prevalence of Strongyloides stercoralis infection in Côte d’Ivoire [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50]. (C) Prevalence of Strongyloides stercoralis infection ienin [136,137,138]. (D) Prevalence of Strongyloides stercoralis infection in Ghana, Mauritania, and The Gambia [12,13,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,139,140,141]. (E) Prevalence of Strongyloides stercoralis infection in Burkina Faso, Cape Verde, Guinea, Guinea-Bissau, Liberia, Niger, Senegal, Sierra Leone, and Togo [14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,141,142,143,144,145,146,147,148]. Grey square represents the weight of each study in the meta-analysis. The blue diamond displays overall or subtotal pooled prevalence of S. stercoralis infection. The width of the diamond shows the 95% CI of the pooled prevalence of the infection.
Tropicalmed 10 00321 g006aTropicalmed 10 00321 g006bTropicalmed 10 00321 g006cTropicalmed 10 00321 g006dTropicalmed 10 00321 g006e
Figure 7. Forest plot showing the odds ratio of Strongyloides stercoralis infection among HIV and malaria patients in West Africa [69,85,86,87,88,89,133]. Grey square represents the weight of each study in the meta-analysis. The box shows the odds ratio of each study. The vertical line corresponds to no effect.
Figure 7. Forest plot showing the odds ratio of Strongyloides stercoralis infection among HIV and malaria patients in West Africa [69,85,86,87,88,89,133]. Grey square represents the weight of each study in the meta-analysis. The box shows the odds ratio of each study. The vertical line corresponds to no effect.
Tropicalmed 10 00321 g007
Table 1. Demographic characteristics of the individual studies stratified by West African countries.
Table 1. Demographic characteristics of the individual studies stratified by West African countries.
CountryN
Individual Studies
Study SettingStudy Population References
SchoolHospitalCommunityAll Age and SexPSACSACPSAC + SACFemales
The Gambia191801001900Kositz et al. (2022) [12], Sanyang et al. (2021) [13]
Liberia220000200Sodeman (1979) [14]
Togo1011872100Korbmacher et al. (2018) [15], Gbadoé et al. (2005) [16], Aplogan et al. (1990) [17], Lapierre et al. (1988) [18]
Guinea-Bissau511311120Farrant et al. (2020) [19], von Huth et al. (2019) [20], Steenhard et al. (2009) [21], Lebbad et al. (2001) [22], Carstensen et al. (1987) [23]
Sierra Leone300330000Bailey et al. (2006) [24], Gbakima (1994) [25], Whitworth et al. (1991) [26]
Cape Verde101000010Colito et al. (2021) [27]
Guinea10001000820Beavogui et al. (2021) [28], Glickman et al. (1999) [29], Gyorkos et al. (1996) [30]
Côte
d’Ivoire
4636195125150Becker et al. (2015b) [31], Becker et al. (2015a) [32], Adoubryn et al. (2012) [33], Becker et al. (2011) [34], Traoré et al. (2011) [35], Djohan et al. (2010) [36], Diakité et al. (2010) [37], Glinz et al. (2010b) [38], Glinz et al. (2010a) [39], Menan et al. (2008) [40], Evi et al. (2007) [41], Yapi et al. (2006) [42], Dancesco et al. (2005) [43], Agbaya et al. (2004) [44], Menan et al. (1997b) [45], Menan et al. (1997a) [46], Therizol-Ferly et al. (1989) [47], Penali et al. (1988) [48], Haller and Lauber (1980) [49], Nozais et al. (1975) [50]
Nigeria1196925254116674Gbonhinbor et al. (2024) [51], Agabi et al. (2023) [52], Alade et al. (2023) [53], Imalele et al. (2023) [54], Udeh et al. (2023) [55], Evbuomwan et al. (2022) [56], Inah et al. (2022) [57], Nwankwo et al. (2021) [58], Yaro et al. (2021) [59], Nnolim et al. (2020) [60], Abe et al. (2019) [61], Dahal et al. (2019) [62], Dawaki et al. (2019) [63], Udeh et al. (2019) [64], Ayede et al. (2018) [65], Akinbo and Akanbi (2018) [66], Amoo et al. (2018) [67], Gbebi et al. (2018) [68], Ojurongbe et al. (2018) [69], Adeniran et al. (2017) [70], Inyang-Etoh et al. (2017) [71], Ivoke et al. (2017) [72], Muazu et al. (2017) [73], Shitta and Akogun (2017) [74], Taiwo et al. (2017) [75], Douglas and Amadi (2016) [76], Obateru et al. (2016) [77], Abah and Arene (2015) [78], Agu et al. (2013) [79], Ohaeri and Orji (2013) [80], Abaver et al. (2012) [81], Akinbo et al. (2012) [82], Oguanya et al. (2012) [83], Abaver et al. (2011) [84], Akinbo et al. (2011b) [85], Akinbo et al. (2011a) [86], Akinbo and Ormegie (2011) [87], Sanyaolu et al. (2011) [88], Babatunde et al. (2010) [89], Dada-Adegbola et al. (2010) [90], Damen et al. (2010) [91], Umar and Bassey (2010) [92], Houmsou et al. (2009) [93], Morenikeji et al. (2009) [94], Ibidapo and Okwa (2008) [95], Adeoye et al. (2007) [96], Agbolade et al. (2007) [97], Ikeh et al. (2007) [98], Ugbomoiko and Ofoezie (2007) [99], Wagbatsoma and Aisien (2005) [100], Anosike et al. (2004) [101], Dada-Adegbola and Bakare (2004) [102], Anyaeze (2003) [103], Okoronkwo (2002) [104], Ozumba and Ozumba (2002) [105], Nwokediuko et al. (2002) [106], Nwaorgu et al. (1998) [107], Sodipo et al. (1997) [108], Udonsi et al. (1996) [109], Asaolu et al. (1992) [110], Akogun (1989) [111], Holland et al. (1989) [112], Arene (1984) [113]
Ghana282521135316Backhaus et al. (2024) [114], Deku et al. (2024) [115], Donkoh et al. (2023) [116], Akenten et al. (2022) [117], Fornace et al. (2022) [118], Aninagyei et al. (2020) [119], Cunningham et al. (2020) [120], Kpene et al. (2020) [121], Adu-Gyasi et al. (2018) [122], Cunningham et al. (2018) [123], Forson et al. (2017) [124], Tay et al. (2017) [125], Agboli et al. (2015) [126], Danikuu et al. (2015) [127], Duedu et al. (2015) [128], Tay et al. (2011) [129], Baidoo et al. (2010) [130], Yatich et al. (2010) [131], Verweij et al. (2009) [132], Yatich et al. (2009) [133], Yelifari et al. (2005) [134], Annan et al. (1986) [135]
Benin676601106600Boko et al. (2016) [136], Ibikounlé et al. (2014) [137], Chippaux et al. (1990) [138]
Mauritania161015140200Ba et al. (2024) [139], Urbani et al. (1997) [140], WHO (1995) [141]
Senegal403140000Diongue et al. (2017) [142], Sow et al. (2017) [143], Ndiaye et al. (2013) [144], Salem et al. (1994) [145]
Niger100110000Mouchet et al. (1988) [146]
Burkina Faso505020003Sangaré et al. (2021) [147], Sangaré et al. (2015) [148], Karou et al. (2011) [149]
MaliNo data
Total336196429892101932813
Table 2. Pooled prevalence of Strongyloides stercoralis infection in West Africa by demographic characteristics.
Table 2. Pooled prevalence of Strongyloides stercoralis infection in West Africa by demographic characteristics.
VariableSample SizeNo PositivePooled Prevalence (%)95% CII2 (%)p-Value
Population
All age and sex85,08243334.94.2–5.598.3<0.001
PSAC19271276.33.7–8.983.0<0.001
SAC31,37614697.16.1–8.190.6<0.001
PSAC + SAC19,9553242.01.4–2.590.3<0.001
Females4772911.60.8–2.475.9<0.001
Study setting
School34,58213255.54.7–6.391.5<0.001
Hospital49,2666291.51.2–1.891.0<0.001
Community59,26443906.65.7–7.598.3<0.001
Sample size
<10191115449.17.4–10.780.5<0.001
101–100045,97719774.74.1–5.393.1<0.001
1001–10,00042,66113353.12.4–3.898.7<0.001
>10,00045,36324884.20.7–7.799.9<0.001
CI: confidence interval; PSAC: pre-school-aged children; SAC: school-aged children.
Table 3. Meta-regression analysis of Strongyloides stercoralis prevalence in West Africa from 1975 to 2024.
Table 3. Meta-regression analysis of Strongyloides stercoralis prevalence in West Africa from 1975 to 2024.
Variableβ-Coefficient95% CIp-Value
Publication decade0.900.77–1.040.141
Study population0.950.82–1.100.478
Study country1.010.95–1.050.812
Study setting0.920.75–1.120.433
Diagnostic method0.990.97–1.010.540
Sample size0.420.34–0.53<0.001
Table 4. Prevalence of Strongyloides stercoralis infection stratified by West African countries.
Table 4. Prevalence of Strongyloides stercoralis infection stratified by West African countries.
CountryN
Individual
Studies
N
Participants
N
Positive
S. stercoralis PrevalenceReferences
(%)95% CII2p-Value
The Gambia19185920318.911.1–26.888.4<0.001Kositz et al. (2022) [12], Sanyang et al. (2021) [13]
Liberia25498414.99.8–19.962.30.103Sodeman (1979) [14]
Togo10174914910.76.9–14.692.3<0.001Korbmacher et al. (2018) [15], Gbadoé et al. (2005) [16], Aplogan et al. (1990) [17], Lapierre et al. (1988) [18]
Guinea-Bissau526311267.82.4–13.296.4<0.001Farrant et al. (2020) [19], von Huth et al. (2019) [20], Steenhard et al. (2009) [21], Lebbad et al. (2001) [22], Carstensen et al. (1987) [23]
Sierra Leone320761456.95.5–8.320.70.283Bailey et al. (2006) [24], Gbakima (1994) [25], Whitworth et al. (1991) [26]
Cape Verde110576.82.7–13.2Colito et al. (2021) [27]
Guinea101478845.52.8–8.180.8<0.001Beavogui et al. (2021) [28], Glickman et al. (1999) [29], Gyorkos et al. (1996) [30]
Côte d’Ivoire4616,1194645.24.1–6.292<0.001Becker et al. (2015b) [31], Becker et al. (2015a) [32], Adoubryn et al. (2012) [33], Becker et al. (2011) [34], Traoré et al. (2011) [35], Djohan et al. (2010) [36], Diakité et al. (2010) [37], Glinz et al. (2010b) [38], Glinz et al. (2010a) [39], Menan et al. (2008) [40], Evi et al. (2007) [41], Yapi et al. (2006) [42], Dancesco et al. (2005) [43], Agbaya et al. (2004) [44], Menan et al. (1997b) [45], Menan et al. (1997a) [46], Therizol-Ferly et al. (1989) [47], Penali et al. (1988) [48], Haller and Lauber (1980) [49], Nozais et al. (1975) [50]
Nigeria11947,70521065.14.4–5.996.6<0.001Gbonhinbor et al. (2024) [51], Agabi et al. (2023) [52], Alade et al. (2023) [53], Imalele et al. (2023) [54], Udeh et al. (2023) [55], Evbuomwan et al. (2022) [56], Inah et al. (2022) [57], Nwankwo et al. (2021) [58], Yaro et al. (2021) [59], Nnolim et al. (2020) [60], Abe et al. (2019) [61], Dahal et al. (2019) [62], Dawaki et al. (2019) [63], Udeh et al. (2019) [64], Ayede et al. (2018) [65], Akinbo and Akanbi (2018) [66], Amoo et al. (2018) [67], Gbebi et al. (2018) [68], Ojurongbe et al. (2018) [69], Adeniran et al. (2017) [70], Inyang-Etoh et al. (2017) [71], Ivoke et al. (2017) [72], Muazu et al. (2017) [73], Shitta and Akogun (2017) [74], Taiwo et al. (2017) [75], Douglas and Amadi (2016) [76], Obateru et al. (2016) [77], Abah and Arene (2015) [78], Agu et al. (2013) [79], Ohaeri and Orji (2013) [80], Abaver et al. (2012) [81], Akinbo et al. (2012) [82], Oguanya et al. (2012) [83], Abaver et al. (2011) [84], Akinbo et al. (2011b) [85], Akinbo et al. (2011a) [86], Akinbo and Ormegie (2011) [87], Sanyaolu et al. (2011) [88], Babatunde et al. (2010) [89], Dada-Adegbola et al. (2010) [90], Damen et al. (2010) [91], Umar and Bassey (2010) [92], Houmsou et al. (2009) [93], Morenikeji et al. (2009) [94], Ibidapo and Okwa (2008) [95], Adeoye et al. (2007) [96], Agbolade et al. (2007) [97], Ikeh et al. (2007) [98], Ugbomoiko and Ofoezie (2007) [99], Wagbatsoma and Aisien (2005) [100], Anosike et al. (2004) [101], Dada-Adegbola and Bakare (2004) [102], Anyaeze (2003) [103], Okoronkwo (2002) [104], Ozumba and Ozumba (2002) [105], Nwokediuko et al. (2002) [106], Nwaorgu et al. (1998) [107], Sodipo et al. (1997) [108], Udonsi et al. (1996) [109], Asaolu et al. (1992) [110], Akogun (1989) [111], Holland et al. (1989) [112], Arene (1984) [113]
Ghana2836,85426713.72.0–5.498.9<0.001Backhaus et al. (2024) [114], Deku et al. (2024) [115], Donkoh et al. (2023) [116], Akenten et al. (2022) [117], Fornace et al. (2022) [118], Aninagyei et al. (2020) [119], Cunningham et al. (2020) [120], Kpene et al. (2020) [121], Adu-Gyasi et al. (2018) [122], Cunningham et al. (2018) [123], Forson et al. (2017) [124], Tay et al. (2017) [125], Agboli et al. (2015) [126], Danikuu et al. (2015) [127], Duedu et al. (2015) [128], Tay et al. (2011) [129], Baidoo et al. (2010) [130], Yatich et al. (2010) [131], Verweij et al. (2009) [132], Yatich et al. (2009) [133], Yelifari et al. (2005) [134], Annan et al. (1986) [135]
Benin6710,583873.52.1–5.070.3<0.001Boko et al. (2016) [136], Ibikounlé et al. (2014) [137], Chippaux et al. (1990) [138]
Mauritania162503722.91.2–4.668.70.001Ba et al. (2024) [139], Urbani et al. (1997) [140], WHO (1995) [141]
Senegal447721192.80.0–5.997.0<0.001Diongue et al. (2017) [142], Sow et al. (2017) [143], Ndiaye et al. (2013) [144], Salem et al. (1994) [145]
Niger1190060.30.1–0.7Mouchet et al. (1988) [146]
Burkina Faso512,229210.20.1–0.200.758Sangaré et al. (2021) [147], Sangaré et al. (2015) [148], Karou et al. (2011) [149]
Mali
Total336143,11263444.44.1–4.896.8<0.001
CI: confidence interval; PSAC: pre-school-aged children; SAC: school-aged children.
Table 5. Risk factors for Strongyloides stercoralis infection in West Africa, as revealed by a systematic review covering a 50-year period (1975 to 2024).
Table 5. Risk factors for Strongyloides stercoralis infection in West Africa, as revealed by a systematic review covering a 50-year period (1975 to 2024).
Type of PredictorVariableOR95% CIp-ValueReference
DiseaseHIV patients16.20.7–404.70.347[87]
HIV patients1.03.50.966[86]
HIV patients5.31.6–17.80.006[85]
HIV patients4.01.3–13.00.010[89]
HIV patients1.20.9–1.50.067[88]
Malaria2.40.2–39.30.500[69]
Malaria1.40.6–3.2NA[133]
SymptomsAnaemia3.40.2–56.80.383[86]
Anaemia1.7 0.130[19]
Stomach ache2.41.0–5.60.056[34]
Nausea5.01.3–19.3NA[32]
WASH indicatorsUse of community tap water6.21.4–28.20.019[34]
Water or tissue available sometime1.40.8–2.50.080[13]
Water and soap available0.90.5–1.60.613[13]
DemographyPre-school-aged children0.3 <0.010[19]
7–10 years3.31.8–5.8<0.001[13]
InterventionFemales1.10.7–1.70.818[13]
MDA0.40.2–1.00.037[12]
CI: confidence interval; MDA: mass drug administration; OR: odds ratio; WASH: water, sanitation, and hygiene.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Assaré, R.K.; Ouattara, M.; Becker, S.L.; Bassa, F.K.; Diakité, N.R.; Utzinger, J.; N’Goran, E.K. Strongyloides stercoralis Infection in Humans in West Africa, 1975–2024: Systematic Review and Meta-Analysis. Trop. Med. Infect. Dis. 2025, 10, 321. https://doi.org/10.3390/tropicalmed10110321

AMA Style

Assaré RK, Ouattara M, Becker SL, Bassa FK, Diakité NR, Utzinger J, N’Goran EK. Strongyloides stercoralis Infection in Humans in West Africa, 1975–2024: Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease. 2025; 10(11):321. https://doi.org/10.3390/tropicalmed10110321

Chicago/Turabian Style

Assaré, Rufin K., Mamadou Ouattara, Sören L. Becker, Fidèle K. Bassa, Nana R. Diakité, Jürg Utzinger, and Eliézer K. N’Goran. 2025. "Strongyloides stercoralis Infection in Humans in West Africa, 1975–2024: Systematic Review and Meta-Analysis" Tropical Medicine and Infectious Disease 10, no. 11: 321. https://doi.org/10.3390/tropicalmed10110321

APA Style

Assaré, R. K., Ouattara, M., Becker, S. L., Bassa, F. K., Diakité, N. R., Utzinger, J., & N’Goran, E. K. (2025). Strongyloides stercoralis Infection in Humans in West Africa, 1975–2024: Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease, 10(11), 321. https://doi.org/10.3390/tropicalmed10110321

Article Metrics

Back to TopTop